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Abstract 
Background: Newborn infant neurological function can be measured by monitoring 
electrical activity (electroencephalography) or cerebral oxygenation via NIRS (near 
infrared spectroscopy). In practice the clinical applications of electroencephalography 
(EEG) are limited to monitoring infants following moderate to severe hypoxic 
ischemic injury (HIE), and for the detection of seizures in at risk infants. NIRS 
monitoring has been the focus of a number of research trials but has no clinical 
applications in the immediate newborn period to date, and is not routinely performed 
in neonatal units.  
Aim: To assess the feasibility of infant neuromonitoring in the immediate period in 
two important clinical scenarios. Firstly, to assess the feasibility of monitoring brain 
activity during the first minutes of life in healthy term infants. Secondly, to assess the 
feasibility and utility of monitoring newborn preterm infants’ brain activity and 
cerebral oxygenation in the context of an interventional randomized controlled trial.  
Methods:  
1. Healthy term newborn infants had EEG monitoring performed for the first ten 
minutes of life. EEG was assessed both qualitatively and quantitatively. All infants 
had respiratory function monitoring performed simultaneously. 
2. Forty-five infants (< 32 weeks gestation) were randomly assigned to different 
methods of newborn infant cord clamping. All infants had EEG and NIRS monitoring 
for the first 72 hours of life. Quantitative features of EEG and median NIRS values 
were compared between groups at 6 and 12 hours of life as a primary outcome 
measure.   
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Results: 
1. Forty-nine infants had EEG recordings. Median (IQR) age at time of initial EEG 
recording was 3.0  (2·5 to 3·8) minutes. End tidal CO2 and tidal volumes increased 
over the first 3 minutes of life and then stabilized. Good quality EEG, with continuous 
mixed frequency activity with a range of 25-50μV, was observed in all infants. The 
majority of EEG spectral power was within the delta band.  
2. There were 45 infants included. One infant died in the delivery room. Median time 
(IQR) from birth until EEG application was 3.05 (1.85 to 5.38) hrs. For primary 
outcome measures, data was available for 42/44 (95%) at 6 hrs and 44/44 (100%) at 
12 hours. There was no significant difference between groups for measures for EEG 
values or cerebral NIRS.  
Conclusion: Infant neuromonitoring in the immediate newborn period is feasible in 
the first minutes of life in healthy term infants and within the first hours of life in 
preterm infants. Normative quantitative data for electrical activity in healthy newborn 
term infants during the first minutes of life is described for the first time. 
Neuromonitoring during the first day of life as an outcome measure for preterm 
interventional trials is possible and the outcomes from this research is promising for 
further trials.  
 14 
Aims and Objectives 
The primary aim of this thesis is to assess infant neuromonitoring in the immediate 
newborn period. A real time objective measure of brain function is currently not 
readily available in the immediate newborn period. The potential benefits of having 
real time information on infant brain function for clinicians will be explored. 
In this thesis, I will describe the research performed which aimed to assess the 
feasibility of acquiring very early EEG data in term infants, assessing the quality of 
data acquired, and producing normative EEG data in the immediate newborn period. I 
will also describe respiratory physiological parameters in the immediate newborn 
period to clarify the physiological stage of newborn transition that the EEG data 
acquired represented.  
Furthermore, a major objective of this research was to perform neuromonitoring in 
preterm infants as early as possible, in the context of a randomized controlled trial, 
and to utilize measures of brain activity and cerebral oxygenation as outcome 
measures. It had been reported in a large Cochrane review that the incidence of 
intraventricular haemorrhage was lower in preterm infants following delayed cord 
clamping, or umbilical cord milking compared to infants who received immediate 
cord clamping(1, 2). The physiological basis for an increased incidence has been 
supported by work with animal models (3). However, a reduced incidence of 
intraventricular haemorrhage following DCC or UCM has not translated into 
improved neurodevelopmental outcomes to date (1). The objective within this thesis 
was to assess whether different patterns of cerebral function could be identified 
following different cord clamping strategies. 
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In summary the aims were: 
1. To assess the feasibility of EEG monitoring in term infants in the immediate 
newborn period  
2. To produce normative EEG data ranges for term infants in the first 10 minutes 
of life, and assess whether these values correlate with newborn transitioning 
3. To assess the value of preterm infant neuromonitoring  (EEG & NIRS) in the 
immediate newborn period in a randomised controlled preterm infant study on 
different cord clamping strategies 
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Chapter Summary 
Chapter 1: Current modalities for monitoring infants in the immediate newborn 
period and the rationale for neuromonitoring 
Current modalities for physiological monitoring of newborn infants are described. 
Current international guidelines and ongoing research topics are explored. The current 
methods and published research on neuromonitoring in the immediate newborn period 
is described, and a systematic review on EEG monitoring in the delivery room is 
presented. The rationale for investigating the feasibility and utility of EEG monitoring 
in the immediate newborn period for term and preterm infants is discussed.  
 
Chapter 2:  General methodology 
The setting for each study, the subjects and recruitment process, interventions and 
monitoring techniques, principal outcomes measured, ethics, and the type of statistical 
analysis applied are described.   
Chapter 3: Respiratory Adaptation in Term Infants following Elective Cesarean 
Section 
The timeframe for respiratory adaptation in healthy term infants following elective 
cesarean section has not been described in detail previously. Prior to the study 
reported in Chapter 4 members of our research team had recruited fifty term infants in 
a study where respiratory function monitoring was performed following elective 
caesarean section. It was decided to continue the recruitment for this study in parallel 
with the recruitment process described in Chapter 4. This allowed for accurate 
documentation of respiratory adaptation in a larger cohort of infants. Therefore the 
understanding of the EEG recordings obtained in Chapter 4 was enriched as it could 
be clearly seen that our cohort of infants had achieved respiratory adaptation by the 
time EEG recordings were obtained.  
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Chapter 4:  EEG for the Assessment of Neurological Function of Term Infants in 
the Immediate Newborn Period 
 
The first objective of this research was to assess the feasibility of obtaining EEG 
recordings during the immediate newborn period. This was a prospective study where 
fifty term infants born by elective caesarean section were antenatally recruited and 
had EEG monitoring for the first ten minutes of life. This is the first study to describe 
quantitative features of brain activity in healthy term infants in the immediate 
newborn period.  
 
  
Chapter 5: Neuromonitoring in the immediate newborn period in a preterm 
infant randomized controlled trial: Clamping the Umbilical cord in Premature 
Deliveries (CUPiD)  
 
The second objective of this research was to assess the feasibility of monitoring 
newborn preterm infants’ brain activity and cerebral oxygenation in the context of an 
interventional randomized controlled trial. In this chapter we describe a prospective, 
registered randomized controlled trial in preterm infants designed to incorporate 
measures of EEG and NIRS as primary outcome measures. Different umbilical cord 
clamping interventions was chosen as a study topic as there is currently much debate 
regarding neurological outcomes following different interventions. International 
guidelines advocate performing trials to further assess which approach is superior.   
  
Chapter 6:  Conclusion and future directions 
The results of this research are evaluated and future directions based on the results are 
discussed.  
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Chapter 1  
Current modalities for monitoring infants in the 
immediate newborn period and the rationale for 
neuromonitoring 
1.1 Introduction  
In recent decades, we have witnessed a significant increase in the number of 
monitoring options for newborn infants. Examples include cardiac 
(electrocardiography (ECG), echocardiography and non-invasive cardiac output 
monitoring), respiratory (capnography and respiratory function monitoring), and 
neurological monitoring (electroencephalography and near infrared spectroscopy). 
However, at present, routine monitoring of preterm and term infants requiring 
advanced stabilisation in the immediate newborn period has changed very little over 
time.  
 
As adjuncts to clinical monitoring during initial infant stabilisation in the delivery 
room (DR), the recent 2015 ILCOR recommendations advise the use of two objective 
assessment tools as routine for preterm, and term deliveries where advanced 
stabilisation measures are expected: 1) pulse oximetry (with or without ECG) to 
regulate oxygen delivery, and 2) exhaled carbon dioxide (CO2) detectors for 
confirmation of correct endotracheal (ET) tube placement (4). These two devices 
generate real-time accurate physiological data and, if recorded, document changing 
observations over time. The information provided assists in clinical decision-making 
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in real-time and has the potential to improve both short and long-term outcomes for 
newborn infants.   
 
The relative lack of monitoring options in the DR is both a reflection of the 
difficulties in acquiring the information, and interpreting this data for decision making 
in real-time. As Bradley and Field reflected, “not all that is measurable is of value, 
and not all that is of value can be measured” (5). Monitoring techniques encompass 
simple clinical evaluation to the potential role of newer monitoring devices, including 
monitoring cerebral activity and cerebral oxygenation during the first minutes of life.   
It is important to understand the historical perspective and current available methods 
for monitoring newborn infants in order to understand the rationale for infant 
neuromonitoring in the immediate newborn period. A summary of current newborn 
infant monitoring techniques and newer proposed methods can be seen in Table 1.1. 
 
1.2 Review of non- neurological infant monitoring in the immediate newborn 
period  
 
1.2.1 Historical context and the Apgar score 
Dr. Virginia Apgar, in 1953, was the first to describe newborn monitoring in the 
immediate newborn period in a methodical manner. The Apgar score is the sum of 
values based on the newborn respiratory (respirations, skin colour), cardiovascular 
(heart rate, skin colour) and neurological (muscle tone, reflex irritability) systems (6). 
With the exception of heart rate (HR), all of the variables are based on visual 
inspection of the infant and as such are somewhat subjective. Large cohort studies 
identified that 5 minute Apgar scores of < 7 were associated with increased risk of 
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neonatal death and cerebral palsy in both term and preterm infants, indicating that 
early clinical assessments may be reliable and meaningful for newborn infants (7-9). 
On addressing the inter rater variability of the score, Apgar reported that, “When two 
or more people decide independently, we find a range of one value above or below a 
decided score to be the widest variation” (10, 11).  Currently, Apgar scores remain 
central to our interpretation of a newborn’s condition at birth. They are routinely 
assigned to all infants in the immediate postnatal period and are usually collected as 
part of research trials both to assess baseline characteristics of study participants and 
in some cases as outcome measures. Newborn resuscitation guidelines advise 
initiating support during infants’ transition based on assessment of respirations, tone 
and heart rate, which are all components of the Apgar score (12-14).  
 
However, more recent studies have shown poor inter and intra rater reliability with 
regard to Apgar score assignment, especially when the infant is preterm or ventilated 
(15, 16). The ability of the five minute Apgar score to predict outcome seem less 
likely than previously thought. Singh et al has shown that in very preterm infant 
delivery there is no Apgar score cutoff below which “a burdensome outcome was 
assured or above which an unscathed outcome was likely”. Five minute Apgar score 
and HR values also displayed poor sensitivity and specificity for either survival or 
survival without disability (17). Manley and colleagues asked clinicians to predict the 
outcome of preterm infants (<26 weeks gestation) based on their clinical appearance 
in the DR, at pre-specified time points of 20 seconds, 2 minutes and 5 minutes. This 
study was based on video recordings of the preterm infants, and monitors displaying 
HR and oxygen saturation (SpO2) values were visible. Trainees and staff 
neonatologists predicted infant survival poorly at each time point. The authors 
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concluded that neonatologists’ “reliance on initial appearance and early response to 
resuscitation in predicting survival for extremely premature infants is misplaced” 
(18).    
 
Updated Apgar scoring systems have been proposed and allow for more appropriate 
descriptions of the condition of the preterm infant at birth. The Combined-Apgar 
score reports the infants’ score in each of the five components of the Apgar score 
(specified Apgar score), and the interventions required to achieve this score 
(expanded Apgar score) (19, 20). This Combined-Apgar score has been shown to be 
superior in predicting outcome in preterm infants when compared to the conventional- 
Apgar score (21).  However, this updated scoring system has yet to be universally 
adopted and the relevance of conventional Apgar scores in term ventilated, and 
preterm infants remains limited. Therefore, we can conclude that clinical assessments 
of newborn infants are important but limited, and enhanced monitoring of infants is 
required for improved real time information, which is not subject to inter rater 
variability. Clinical parameters such as oxygen saturation, heart rate, peripheral 
perfusion and respiratory status have received much attention recently.  
 
1.2.2 Oxygen saturation monitoring 
Clinically, infants transition from blue (cyanotic) to pink (normal oxygen saturations) 
in colour during uncomplicated newborn transition. O’ Donnell and colleagues 
assessed clinical perceptions of newborn infant colour in the DR (22). They found 
wide variation in observations and concluded that, “clinical assessment of a newborn 
infant’s colour may be unreliable”. Assessment of arterial oxygen saturation by pulse 
oximetry is based on the Beere-Lambert law that relates the attenuation of light to the 
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properties of the materials through which the light is travelling; and photo-
plethysmography, a non-invasive optical technique used to detect blood volume 
changes in the microvascular bed of the tissue (23). Aoyagi and Kishi, who realized 
that oxygenated hemoglobin absorbs more light at infrared wavelengths and 
deoxygenated hemoglobin absorbs more light at red wavelengths, developed arterial 
oxygen saturation monitoring by pulse oximetry in 1972. The changes during systole 
and diastole in the ratio of red and infrared light energy absorption is used to produce 
the pulse oxygen saturation (24).  
 
The device was first commercialized in 1981, and the use of pulse oximetry for 
continuous oxygen monitoring in newborns was first described in 1986 (25). The 
clinical benefits of pulse oximetry were quickly recognised, and it has become the 
mainstay of non-invasive, continuous SpO2 monitoring in newborns (26). Oxygen 
saturation monitoring of preterm and compromised term infants is now standard in the 
DR and these values serve as a guide to stabilisation (25, 26). The titration of oxygen 
therapy in preterm newborn stabilisation is now routine to achieve targeted saturations 
by 10 minutes of age (27, 28). Dawson and colleagues have published oxygen 
saturation percentile charts for the first 10 minutes of life (27). In their study of over 
450 infants, they observed the SpO2 values of preterm infants increased at a slower 
pace than term infants. At 5 minutes, the median (interquartile range) SpO2 was 86% 
(80-92) in preterm and 92% (83-96) in term infants.  They have published 3 sets of 
percentile charts based on gestation (>37 weeks, 32-37 weeks, and < 32 weeks), 
which may guide neonatal teams in titrating oxygen therapy in the DR. However, 
these ranges were developed in a cohort of infants born when immediate cord 
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clamping was frequently practiced following delivery. These ranges may not be as 
relevant where delayed clamping is practiced.  
 
Pulse oximetry has gained widespread acceptance in neonatal care over the past three 
decades because of its reliability, ease of use and lack of heat-related complications. 
The main physiological limitation of pulse oximetry is the inability to detect 
hyperoxemia in the higher SpO2 range (>90%) because of the shape of the oxygen-
hemoglobin dissociation curve. Thus, relatively small increases in SpO2 can be 
associated with a large increase in PaO2 (29-31). This is particularly important for 
preterm infants receiving supplemental oxygen because of their vulnerability to 
oxygen toxicity and oxidative stress (32).  Despite this limitation, pulse oximetry is 
the gold standard for monitoring oxygen saturation during preterm infant stabilisation, 
and should be used following all preterm and compromised term deliveries.  
 
1.2.3 Heart rate monitoring 
Monitoring HR helps to guide newborn transition and the need for intervention in the 
immediate newborn period. Current recommendations advise that HR should be 
assessed clinically, and if positive pressure ventilation is commenced HR should be 
monitored by pulse oximetry, with the option of additional ECG monitoring (4).  
 
Whilst clinical assessment of HR by auscultation at the apex is more accurate than 
assessment by palpation of the umbilicus, all clinical assessments may misrepresent 
the actual HR (33). Kamlin et al. compared palpation and auscultation of HR to ECG 
determined HR in term newborns in the DR. They found that clinical assessments 
were inaccurate, and infant HR was underestimated when compared with ECG HRs 
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(34). Hawkes et al. studied healthcare professionals as they palpated a simulated 
pulsating umbilicus, listened to a tapping heart rate, or auscultated a simulated HR. 
They found that while study participants performed well at identifying HR > 100 
beats per minute (bpm), almost two thirds of participants failed to recognize a HR less 
than 60 bpm for all methods of assessment (35). These findings emphasize the 
importance of early accurate objective HR monitoring during preterm infant transition 
for identification of infants who may require support or active resuscitation (HR less 
than 60 bpm).  
 
Pulse oximetry provides real time accurate information about the HR of infants (36).  
However, pulse oximetry values are not available immediately as the sensor takes 
time to apply correctly and once applied, there is a delay before the monitor provides 
a reading. Limb perfusion will affect the time taken to achieve a pulse oximeter heart 
rate (36).  Studies that have assessed the feasibility of obtaining prompt and reliable 
pulse oximetry readings have reported times to signal acquisition of between 1 and 2 
minutes after delivery (28, 37). There is conflicting evidence as to whether quicker 
signal acquisitions are obtained by applying the sensor cable to the oximeter prior to 
applying the sensor to the infant, or after. Observational studies reported that the 
quickest method involved turning on the pulse oximeter prior to delivery, applying the 
sensor to the infant’s right hand and then connecting the cable of the sensor to the 
oximeter. This results in mean readings within 25 seconds of reaching the 
resuscitation table in a research setting (37, 38). A recent randomized controlled trial 
(RCT) in the DR contradicted these findings and found significantly faster signal 
acquisition times in infants who had the sensor connected to the oximeter first (39). A 
limitation of pulse oximetry HR monitoring is that HRs < 100 bpm are not 
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consistently detected, and in a study by Kamlin et al were only reported 89% of the 
time (36).  
 
 ECG monitoring can provide accurate HR values sooner than pulse oximetry 
following delivery (36, 40). The electrodes can be applied quickly and there is little 
lapse in time waiting for monitor readings to appear. Katheria and colleagues reported 
that median times to acquire a signal from ECG and pulse oximetry were 4 seconds 
and 32 seconds respectively (40). A limitation of ECG monitoring is the risk of 
pulseless electrical activity being misinterpreted as HR on ECG (41).  Doppler 
ultrasound blood flow HR assessments in the DR are accurate compared with clinical 
and pulse oximetry assessments (42). Measurements can be taken through a 
polyethylene bag. However, clinical experience is required for accurate assessments 
and continuous measurements are not practical.  
 
ECG monitoring cannot replace the need for pulse oximetry, which is necessary for 
SpO2 monitoring. However, given that ECG monitoring is more accurate than clinical 
estimations, ECG may prevent unnecessary interventions secondary to false clinical 
estimations of low HR. Alternatively, it could increase interventions, which may or 
may not be appropriate, as a result of earlier accurate bradycardia detection. Whilst 
awaiting further evidence, there are a few important points to be made: initiation of 
ECG monitoring in the DR is easily achievable, is more accurate than clinical 
assessment and provides HR values more expediently than pulse oximetry. Clinical 
trials are required to assess whether ECG monitoring affects the frequency of 
stabilisation interventions, and ultimately whether its use affects stabilisation 
outcomes.   
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1.2.4 Peripheral perfusion monitoring 
Peripheral perfusion is determined by cardiac output and the caliber of the vessels 
transporting blood to the peripheries. Current clinical methodologies for non-invasive 
monitoring of peripheral perfusion include assessments of capillary refill time, 
peripheral temperatures, and palpation of peripheral pulses. Each method relies on 
subjective assessments and continuous measurements are impractical. Blood pressure 
monitoring by Doppler and oscillometric methods are feasible in the DR and 
measurements for term infants have been reported (43).  However, non- invasive 
measurements are not reliably consistent in preterm neonates and invasive BP 
monitoring is not practical within the DR setting. Interpretation of and intervention 
based on non-invasive blood pressure measurements in the immediate newborn period 
is currently not recommended.  
 
A recent review by Baik et al. identified four studies of echocardiographic monitoring 
during newborn stabilisation in term infants (44-48). Left ventricular output and 
stroke volume increased over the first 15 minutes of life and one study reported an 
increase in left to right shunting across the ductus (46-48). The studies did not assess 
echocardiographic measurements of HR.  The authors of the review concluded that 
echocardiographic monitoring in the DR would enhance our knowledge about 
“cardiac function changes” (44). However, it does not add useful clinical information 
during newborn stabilisation, and routine monitoring is not advised.  
 
Non-invasive continuous cardiac output monitoring (NICOM) is now feasible in 
neonates (49). This technology is based on the assumption that changes in the 
resistance to electrical currents captured by electrodes on the thorax are directly 
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related to changes in aortic volume during different stages of the cardiac cycle (32).  
NICOM measurements correlate well with timed echocardiographic measurements 
(49, 50).  However, NICOM may underestimate the actual cardiac output value (49). 
Song and colleagues performed 108 paired NICOM and echocardiography studies in 
40 preterm infants (51). Right and left ventricular output had a high level of 
correlation between the two modalities, even in the presence of a significant ductus 
arteriosus. The level of agreement decreased if the infant was on high frequency 
ventilation. The authors noted that while NICOM was a feasible tool to monitor 
trends in cardiac output, absolute values are not reliable, and they do not support 
routine monitoring.  
 
Perfusion index (PI) monitoring is a non-invasive method of assessing real-time 
peripheral perfusion, derived from, and displayed by the pulse oximeter. Pulse 
oximetry values are derived from red (660nm) and infrared wavelengths (910-940nm) 
(52). By using a third wavelength (800 nm), the overall hemoglobin content can be 
calculated and the pulsatile component of arterial blood can be distinguished from the 
non-pulsatile component (53). Perfusion index has been utilized to monitor preterm 
infants in a number of clinical areas (54).  These include screening for congenital 
cardiac disease (55, 56), predicting low systemic blood flow (57), and assessing 
perfusion following blood transfusion (58). However, while PI values are easily 
obtained in the DR, and normative values for preterm infants in the first day of life 
have been published (59, 60), they are highly variable in the immediate newborn 
period, for both term and preterm infants (61).  There are no trials comparing PI and 
clinical assessments of peripheral perfusion in preterm care, nor trials assessing 
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whether PI monitoring affects preterm outcomes. Therefore, evidence in favour or 
against PI monitoring in the immediate newborn period is lacking.  
 
1.2.5 Respiratory support monitoring 
Lung aeration is a critical point in newborn transition from fetal life. Newborn infants 
are at an increased risk of needing respiratory support following delivery.  Inadequate 
ventilation may result in hypoxia and resultant bradycardia. International guidelines 
advise a stepwise approach to achieving optimal ventilation following delivery and 
prior to escalating cardiovascular support; therefore positive pressure ventilation is 
the cornerstone of neonatal resuscitation (62, 63). It is provided either by mask 
ventilation, single or double nasal prongs or via an endotracheal (ET) tube. Adequate 
airway ventilation is assessed clinically by chest rise, an increase in HR, and 
auscultation for air entry on both sides of the lung fields during DR stabilisation. 
Visual assessments of chest rise are not reliable (64). After initiating mask ventilation 
and if the clinical response is suboptimal, guidelines advise repositioning of the mask 
to optimize the seal and reduce leak, and airway opening manoeuvers to combat 
airway obstruction. If there is no clinical improvement after such interventions a 
definitive airway, in the form of ET intubation is advised (4). The mnemonic 
MRSOPA identifies these methods; improve Mask seal, Re- position the airway, 
Suction and/or Open the mouth, increase the inflation Pressure, and consider an 
Alternative airway.   
 
Monitoring stabilisation efficacy in infants in the NNU is achieved by monitoring 
CO2 levels, which can be achieved by measuring either transcutaneous or exhaled 
CO2 levels. There is very little information on CO2 assessment at birth. Studies in the 
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DR have focused on exhaled CO2 detection, either by qualitative or semi quantitative 
disposable colormetric CO2 detectors that change color upon contact with CO2, or 
quantitative capnography that provides a breath by breath end tidal CO2 measurement 
(65). Quantitative capnography is achieved either by mainstream capnography that 
utilises an infrared absorption technique, or side stream capnography that 
continuously transports a sample of gas to a sampling cell within a monitor. Both 
capnography methods provide a continuous visual display of CO2 values 
(capnometry) (65). 
 
CO2 detectors are routinely used to aid in the assessment of correct ET tube 
placement (12). The use of CO2 detectors reduces the time to confirmation of ET tube 
placement and has been endorsed in resuscitation guidelines (12, 66). Their use may 
be limited by false negative readings, during cardiopulmonary arrest and severe 
airway obstruction (67, 68). Employing quantitative capnography following ET tube 
placement also results in quicker and more accurate confirmation of correct placement 
when compared with clinical assessments (69, 70).  
 
The use of CO2 detectors during face mask ventilation has been shown to help 
determine airway patency on an almost breath-to-breath basis, and can aid 
resuscitation teams in recognizing airway obstruction and leak during DR positive 
pressure ventilation (71-74). However, CO2 monitoring is not routine during mask 
ventilation. Van Os and colleagues displayed the benefits of CO2 detectors in helping 
resuscitation teams to recognize airway obstruction in 24 very low birth weight 
infants during positive pressure support in the DR (71). Quantitative capnography 
during mask ventilation has been shown to improve CO2 elimination with the onset of 
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an infant’s respiratory efforts; however, other authors have not found that it reduces 
the occurrence of hypocapnia or hypercapnia (75, 76). In a recent mannequin study 
quantitative capnography was superior to CO2 detectors in improving efficacy of face 
mask ventilation (77). A recent randomized controlled trial found no significant 
difference in the incidence of normocarbia in the first two hours of life between 
quantitative and qualitative CO2 detection (78). 
 
During newborn stabilisations, the user controls ventilation pressures delivered to the 
infants’ lungs. The lungs of newborn infants are susceptible to injury if exposed to 
high airway pressures. Immature animal models have shown that lung injury can 
occur after a few manual inflations at high pressure (79). On the other hand, face 
mask ventilation can be inadequate secondary to leak, even if the user is highly 
experienced (80, 81). In NNUs ventilation adequacy can be assessed by respiratory 
function monitors (RFMs) which are incorporated into modern ventilators (82). They 
provide information not only on airway pressures, but also on delivered tidal volumes.  
The monitor displays breathing pattern, tidal volumes, flow and pressure waves and 
percentages of gas leak. RFMs have also been used to guide positive pressure 
ventilation in newborn resuscitations (83, 84). Schmolzer and colleagues found that 
RFM use during mask ventilation of preterm infants results in significantly less leak, 
more mask adjustments and a lower rate of excessive tidal volume given (84).  RFMs 
have also been used in a RCT, which displayed improved ventilation with masks 
compared with nasal tubes during stabilisation of preterm infants (85). However, the 
use and interpretation of a RFM can be technically challenging for many 
inexperienced users. Milner and colleagues recently surveyed 51 neonatal trainees 
who had used RFMs during preterm stabilisation (86). They found that the usefulness 
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of respiratory function monitoring was dependent on the trainee’s level of experience, 
and that appropriate responses to the RFM data were more frequent in the hands of 
senior clinicians compared with their junior colleagues. Therefore, although 
beneficial, respiratory function monitoring during facemask ventilation is limited by 
user dependency, and further trials are warranted.  
 
1.2.6 Conclusion 
Objective real time physiological monitors are essential in the care of preterm, and 
term infants requiring advanced stabilisation during the immediate newborn period.  
The monitoring tools described thus far do not provide clinicians with information on 
infant brain health during infant transition, the most vulnerable time for brain injury 
in infancy. Assessing brain health in the immediate newborn period has not been 
prioritized historically nor in current international guidelines for monitoring newborn 
infants. The current methods under investigation for assessing brain health in the 
immediate newborn period are described in the next chapter.  
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Table 1.1 Variables and monitoring tools in the immediate newborn period 
 
1 For preterm infants < 32 weeks gestation in the immediate newborn period 
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1.3 Neuromonitoring in the immediate newborn period  
 
1.3.1 Introduction  
As survival rates continue to improve for term infants following hypoxic ischaemic 
injury (HIE) and preterm infants delivered at the cusp of viability, focus has shifted 
on neuroprotection strategies.  The recent Safeboosc trial suggests that brain 
oxygenation monitoring in the NICU results in a reduction in the percentage of 
cerebral hypoxia sustained by preterm infants (87). At present, assessment of 
neurological wellbeing in the immediate newborn period is based on clinical 
assessment alone. As previously described, assessments of muscle tone and reflex 
irritability are incorporated into the Apgar score (6). The brain is the most vulnerable 
organ in newborn infants. As survival of the most immature infants increase, concerns 
have been raised about increased risks of adverse neurodevelopmental outcomes (88, 
89). Resuscitative measures should aim for the best possible neurological outcomes 
and a non-invasive, continuous measurement of cerebral oxygenation and cerebral 
activity would be ideal, but these currently are not routine and their role in this setting 
has yet to be evaluated. The current and proposed methods for assessing brain health 
are summarised in Table 1.2.  
 
 
 
 
 
 
 
 37 
 
Table 1.2 Methods for assessing neonatal brain health 
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1.3.2 Cerebral blood flow 
Studies that sought to introduce neurological monitoring into the DR initially focused 
on cerebral blood flow using doppler measurements of cerebral or carotid arteries (46, 
90-94). Monitoring was found to be technically difficult and did not provide 
continuous data (95). Furthermore, there is conflicting evidence on the role of 
cerebral Doppler in identifying impaired cerebral autoregulation and resultant 
abnormal cranial ultrasound findings (96, 97).  
 
1.3.3.1 Cerebral oxygenation- Background 
More recently, researchers have concentrated on near infrared spectroscopy (98). 
NIRS provides non-invasive monitoring of regional cerebral tissue oxygenation 
(rcSO2) (99-112).  NIRS was first described in 1977 by Jobsis as a technology that 
was capable of non-invasive monitoring of oxygenation in tissues, and its first use in 
neonates as a cerebral oximeter was described by Brazy et al in 1985 (113).  
 
Since its development and introduction into clinical practice, there has been 
progressive device and probe development resulting in a range of readily available 
and easy to apply machines (114). Currently most available devices are Food and 
Drug Authority approved for use in neonates (115).  
 
NIRS utilizes the transparency of biological tissue to light in the near infrared 
spectrum to measure tissue oxygenation (116). Light in the near infra-red range (700-
1000nm) penetrates the soft tissues and bones, in particular thin tissues which 
includes the thin neonatal cranium (117). Circulating haemoglobin (Hb) absorbs this 
near infrared light and absorption of the transmitted light will differ depending on the 
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HB’s oxygenation state (118). Changes in tissue concentration of oxyhaemoglobin 
(O2Hb) and deoxyhaemoglobin (HHb) can be measured in real time (118). Total 
haemoglobin [tHb = O2Hb+HHb] and haemoglobin oxygen saturation [StO2 
=O2Hb/tHb] can also be calculated (34). With these values a regional cerebral 
oxygenation concentration rcSO2 or haemoglobin difference [HbD=O2Hb-HHb] can 
be calculated. The rcSO2 reflects a regional balance between oxygen supply and 
demand for the underlying tissue (31). In addition cerebral blood volume [CBV], 
cerebral blood flow [CBF] and cerebral fractionated tissue oxygen extraction can be 
estimated [cFTOE = (pSaO2-rcSO2)/pSaO2](43). Increased cFTOE reflects higher 
oxygen consumption in relation to oxygen delivery to the brain and decreased cFTOE 
suggest less utilization of oxygen by the brain tissue (119). Naulaers and colleagues 
showed a positive correlation between tissue oxygenation index (TOI- vascular 
haemoglobin oxygen saturation) and cFTOE during a validation study in piglets (120) 
(121).  
 
NIRS monitoring allows neonatologists to monitor regional cerebral oxygenation 
(rcSO2) in real time, and for indirect assessments of cerebral blood flow (CBF) and 
cerebral tissue oxygen extraction (cTOE) (31). These NIRS indices can also be 
utilised in combination with continuous blood pressure measurements to monitor 
cerebral autoregulation. However, despite the impressive evolution of this device over 
time, its use in neonates is currently predominantly limited to clinical research, with 
very few centres using NIRS as a bedside tool to manage preterm infants (117).  
 
A disadvantage for many clinicians is the wide range of normative rcSO2 values.  
Although the use of NIRS technology as a cerebral monitor has been available for 
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over 30 years establishing reference normative values for cerebral oxygenation in 
neonates has taken time (32, 33). Values of 55% and 85% are currently being used for 
the INVOS device(119)(Table 1.3). The rcSO2 values below 55% represent cerebral 
hypoxia and above 85% represent cerebral hyperoxia. These values of 55% and 85% 
were determined from an INVOS device, with the adult NIRS probes, but reference 
ranges obtained from the newer small neonatal probes, which tends to overestimate 
rcSO2 values measured by the adult probe, may be more appropriate (122). 
 
Table 1.3 NIRS Reference Values  
 
 
 
 
Initial research which established normative rcSO2 values concentrated on animal 
studies. Hou et al, studied the effects of varying cerebral oxygenation on newborn 
pigs (123). NIRS was used to monitor the rcSO2 of 27 newborn pigs. After 
mechanical ventilation and inhalation of 3-11% oxygen for 30 minutes by the 
newborn pigs, the pigs were grouped according to the rcSO2 in the brain caused by 
inhalation of different concentrations of oxygen. There were six animals each in 
rcSO2< 30%, 30-35%, 35-40%, 40-50% groups and three animals in the rcSO2 > 60% 
group (normal control). This study found that under varying degrees of hypoxia, when 
the rcSO2 is between 30% and 40%, brain injury occurs and the functional zones of 
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the mitochondria are injured. When the rSO2 is less than 30%, there was significant 
impairment in physiologic parameters; the oxygen saturation and pH of blood were 
lower than those of the control group, and the blood lactic acid level was higher than 
that of the control group. Also the mean arterial blood pressure (MAP) of the newborn 
pigs was significantly lower than that of the animals in the control group.  
 
Cerebral hyperoxia on the other hand has also been shown to cause damage to the 
immature brain. Yis et al exposed  rat pups from birth until day five to 21% or 80% 
oxygen (124). The neuronal density and apoptosis in CA1 and dentate gyrus of 
hippocampus, prefrontal cortex, parietal cortex, and retro-splenial cortex were 
assessed by immunohistochemistry and ELISA cell death assay. DNA fragmentation 
was detected by an ELISA that is specific for nucleosome-associated cytosolic DNA. 
Neuronal density of the investigated brain areas were significantly decreased in the 
hyperoxia group. Furthermore, using ELISA cell death and TUNEL assays, they 
observed an increased cell death in the developing brain in the hyperoxia group (124).  
 
Gerstner et al investigated pathways of maturation-dependent oligodendrocyte  death 
induced by hyperoxia in vitro and in vivo. In this study, developing and mature 
oligodendrocytes in vitro were exposed to 80% oxygen from 0 to 24 hours (125). 
Lactate dehydrogenase assay was used to assess cell viability. Furthermore, rat pups 
were subjected to 80% oxygen, and their brains were processed for myelin basic 
protein staining. Significant cell death was detected after 6 to 24 hour incubation in 
80% oxygen in pre- oligodendrocytes but not in mature oligodendrocytes. Cell death 
was executed by a caspase-dependent apoptotic pathway. Accumulation of superoxide 
and generation of reactive oxygen species were detected after two hours of oxygen 
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exposure. The group also extended these studies by testing the effects of hyperoxia on 
neonatal white matter. Postnatal day 3 and day 6 rats showed bilateral reduction in 
myelin basic protein expression with 24 hours exposure to 80% oxygen (125).  
Hyperoxia causes oxidative stress and triggers maturation-dependent apoptosis in pre- 
oligodendrocytes, which involves the generation of reactive oxygen species and 
caspase activation, and leads to white matter injury in the neonatal rat brain. These 
observations may be relevant to white matter injury observed in preterm infants (125). 
 
1.3.3.2 Cerebral oxygenation in the immediate newborn period 
Cerebral NIRS in the immediate newborn period remains limited to research studies, 
but emerging data suggest that it may have a significant role in preterm stabilisation 
in the future (113). Cerebral tissue oxygen saturations in preterm infants have been 
shown to correlate well with superior vena cava flow and left ventricular output in the 
first days of life (126, 127).  A number of studies have displayed the feasibility of 
obtaining cerebral oxygenation values using NIRS during newborn transition (95). 
Normative values for infants (predominantly term) not requiring resuscitation in the 
DR have been published recently (106).  
 
NIRS measurements are readily obtained and in a recent study conducted by this 
group, the NIRS values were obtained within seconds of application of the device in 
the DR, in contrast to the variable time for pulse oximetry saturation readings (128).  
Binder et al performed NIRS on 49 preterm infants in the immediate newborn period 
(103). They reported different rcSO2 transition time courses for infants requiring 
respiratory support and those with normal transitions. Infants requiring respiratory 
support had lower rcSO2 values over the first 10 minutes of life before reaching 
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similar steady state levels as their counterparts. Fuchs et al. reported rcSO2 values for 
51 infants weighing less than 1500g (111). Low median rcSO2 values (37%) were 
reported at 1 minute of life, which continuously rose to steady state levels (61-84%) at 
7 minutes of age. rcSO2 values did not differ in relation to the degree of resuscitation 
required in the DR, but it was noted that 2 infants with subsequent IVHs had rcSO2 
values that were < 10
th
 centile for their cohort. Kenosi et al evaluated transitional 
cerebral NIRS values in preterm infants less than 32 weeks and found that preterm 
infants requiring greater than 30 % oxygen to maintain peripheral saturations had a 
significantly higher degree of cerebral hypoxia (128). All infants initially received a 
FiO2 of 0.3 and oxygen was titrated according to standard resuscitation guidelines. 
There were no differences in cerebral hyperoxia between the two groups. These 
findings suggest that some preterm infants may require a more rapid increase in 
oxygen titration in the DR. At present, NIRS remains in the realm of research for 
infant monitoring in the immediate newborn period, but as more studies emerge, we 
believe that it will have a future role in monitoring preterm infants and guiding 
oxygen titration during DR stabilisations.  
Pichler and colleagues recently performed a pilot RCT, in which infants < 34 weeks 
were randomized in the DR either to cerebral NIRS and SpO2 monitoring, or SpO2 
monitoring alone to guide titration of oxygen therapy (129). They found that 
additional NIRS monitoring significantly reduced the time that infants’ rcSO2 was 
<10th centile in the first 15 minutes of life. There was no difference in rates of 
intraventricular haemorrhage (IVH) or abnormal neurological assessments at 
discharge. The clinical trials where NIRS was performed in the immediate newborn 
period are summarized in Table 1.4. Further trials are required to ascertain how 
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oxygen therapy should be guided when rcSO2 and SpO2 values are both available in 
the DR.  
 
Cerebral NIRS monitoring may also have a future in providing outcome measures for 
neonatal studies. A recent RCT randomized infants (28 – 33+6 weeks gestation) to 
receive either 1-3 sustained lung inflations (30 cm H2O for 15 seconds) followed by 
standard respiratory care, or standard respiratory care only (130). Cerebral tissue 
oxygenation values were similar for both groups over the first 15 minutes of life. 
However, cerebral blood volume patterns differed between groups. Cerebral blood 
volume decreased in the control group over time, but remained static in the 
intervention group who received sustained lung inflations. The authors hypothesized 
that differences may have been caused by impaired venous return secondary to 
increased thoracic pressures during sustained lung inflations, with resultant cerebral 
venous stasis. These findings highlight the importance of assessing cerebral 
haemodynamics during interventional neonatal studies.  
 
Guidelines for the use of NIRS monitoring and EEG in NICUs overlap, and it is 
advised that they should be used simultaneously (131). However, EEG in the 
immediate newborn period has received little attention in the literature.  
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Table 1.4 A summary of neonatal studies assessing cerebral oxygenation in the 
immediate newborn period 
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1.3.4.1 Electroencephalography- Background 
Electroencephalography (EEG) was first discovered in 1875, by an English physician 
Richard Caton, who observed the EEG from the exposed brains of rabbits and 
monkeys. In 1924, Hans Berger, a German neurologist made the first EEG recording 
from the human scalp, by using radio equipment to amplify the electrical activity of 
the brain, and obtained a written output on paper. He claimed that brain activity that is 
observed through the use of EEG can change in a consistent, reliable and recognizable 
fashion when the state of the patient changes, such as going from relaxation to 
alertness, sleep, and lack of oxygen (132). This breakthrough gave rise to further 
research and the varied applications of EEG in use today. 
EEG consists of the summed electrical activities of populations of neurons. The 
neurons are excitable cells with characteristic intrinsic electrical properties, and their 
activity produces electrical and magnetic fields. These fields may be recorded by 
means of electrodes.  
There are two main types of neuronal activity, action potentials and postsynaptic 
potentials (133):   
1. Action potentials are the result of the very rapid depolarization of a neuron 
mediated mainly by changes in permeability of the membrane to sodium and 
potassium ions. They occur when the cell depolarizes to a certain degree from 
its negative resting state potential. Once the threshold is reached, there is a 
rapid firing of the action potential (about 1 ms) from the beginning of the axon 
at the cell body down to the axon terminals. Due to action potentials being 
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very rapid and brief, the electrodes placed on the scalp simply cannot detect 
them, and it is not possible to monitor by EEG. 
2. Postsynaptic potentials are voltages produced when the neurotransmitters bind 
to the receptors on the membrane of the postsynaptic cell, making ion 
channels open or close. They are mediated by a number of neurotransmitter 
systems and generally entail slower changes in membrane potentials. The 
change in electrical charge outside the membrane lasts in the extra-cellular 
space for up to 200 ms. The extra-cellular electrical charge, positive or 
negative, is what is measured with electrodes placed on the scalp. Therefore, 
EEG is a measure of summated postsynaptic neuronal activity in the cortex 
and represents a sum of excitatory and inhibitory postsynaptic potentials.  
 
EEG exhibits a rich variety of frequencies, amplitudes and waveform morphologies 
from all monitored brain regions. The most familiar classification uses EEG 
waveform frequency (Alpha waves - 8-13 Hz, Beta waves - >13 Hz, Theta waves - 
3.5-7.5 Hz, Delta waves - <3 Hz)(134)(Figure 1.1). Neonatal EEG can be assessed 
qualitatively and quantitatively. The neonatal EEG contains complex spatiotemporal 
information and interpretation is more complex than the interpretation of other vital 
sign signals such as heart rate or respiratory rate. Qualitative EEG analysis is mainly 
used for clinical purposes. It is based on visual interpretation of the EEG signal and 
describes such background features as amplitude, frequency, continuity of the EEG 
and sleep–wake cycling (SWC). Quantitative EEG analysis is a method 
predominantly used in research and includes time and frequency domain analysis. 
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Figure 1.1: EEG waveforms of varying frequencies 
 
1.3.4.2 Electroencephalography applications  
EEG has a range of clinical and research applications (135): 
1. Monitor human brain development 
2. Investigate epilepsy, locate seizure origin, and assess response to anti-epileptic 
treatment 
3. Monitor alertness, coma, and brain death 
4. Locate areas of damage following head injury, or pathological processes 
5. Investigate sleep patterns and disorders 
All of the above are relevant to neonatal care and EEG has become more common in 
NICUs over the past two decades in both clinical and research domains. In contrast to 
cerebral blood flow and NIRS, EEG has well documented applications in the clinical 
management of newborn infants (6).  Its usefulness includes monitoring infants with 
perinatal asphyxia (7-10), the diagnosis of seizures (11-13), and more recently in 
assessing the long-term prognosis of premature infants (14). 
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1.3.4.3 EEG in the immediate newborn period- term infants 
The immediate postnatal period is the time when EEG is often performed on critically 
ill term neonates. In infants with hypoxic ischaemic encephalopathy (HIE), multi-
channel and amplitude integrated EEG are increasingly being used to decide 
eligibility for therapeutic hypothermia (136). The EEG is exquisitely sensitive to any 
impairment in oxygen delivery to the brain. EEG is of the order of microvolts and has 
a temporal resolution that is much higher than functional MRI and can display brain 
activity on a millisecond scale. A reduction in oxygen leads to an immediate 
suppression of synaptic transmission with a reduction (often complete suppression) in 
EEG amplitude (137, 138).  This adaptive response, believed to be mediated by 
multiple inhibitory neuromodulators including adenosine, to hypoxia may be 
protective by decreasing energy consumed by the generation of synaptic potentials 
(139). If cerebral hypoxia is sustained however, EEG amplitudes remain severely 
reduced and membrane failure will eventually occur accompanied by energy 
depletion and cell damage (140) . Thus, sustained suppression in the EEG signals a 
risk of impending brain injury.  
Decisions regarding long-term prognosis following neonatal HIE are made based on 
qualitative EEG analysis. Low background amplitude and discontinuity of EEG 
activity (burst suppression) occur following significant hypoxic-ischaemic injury, and 
are associated with a poor prognosis (141). Disruption of sleep wake cycling has been 
described in neonatal post-asphyxial injury, and its absence soon after birth has been 
associated with a poor neurodevelopmental outcome (142). In neonates with hypoxic 
ischaemic encephalopathy (HIE), an EEG showing sustained suppression for hours 
after birth has long been associated with a very poor outcome (143-146). Neonatal 
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EEG monitoring is recommended for all infants with moderate and severe HIE, and 
neonatal teams are now familiar with its application in NICUs.  
Previous studies  have  shown that the EEG of fetal sheep can be recorded during 
labour (137, 147, 148). Thaler and colleagues performed intrapartum EEG on 
fourteen women with uncomplicated pregnancies (149). A clinical trial of EEG 
monitoring during labour is also currently underway 
(https://clinicaltrials.gov/ct2/show/NCT03013569). During normal labour, the fetus is 
exposed to brief but repeated episodes of hypoxia which are balanced by the fetus’s 
striking ability to adapt to these episodes (150). Fetal EEG monitoring in both human 
and animal studies during labour has shown that these episodes are associated with 
rapid EEG amplitude reduction and also with fast amplitude recovery as soon as the 
uterine contraction ends (137, 140). Fetal EEG monitoring has clear benefits for the 
early recognition of hypoxic ischaemic (HI) injury but requires considerable research 
before it is adopted as a routine tool for fetal surveillance. Neontal EEG acquisition in 
the immediate newborn period on the other hand is much more feasible and may 
quickly identify those neonates that have not tolerated labour and delivery very well, 
which will be seen as suppression or disrupted patterning on the EEG.  
An early EEG in the DR of an infant requiring advanced stabilisation will indicate if 
EEG activity is present or not or if EEG activity returns following this stabilisation 
process. We know that EEG activity should recover immediately following 
restoration of oxygen delivery to the brain. If EEG activity does not return 
immediately post resuscitation or activity is severely disrupted, this may indicate that 
the infant is at risk of HI brain injury. This could provide a clear indication for 
immediate passive cooling prior to transfer to the NICU. This early indication of 
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cerebral function is very important as Thoresen et al have shown that infants cooled 
within 3 hours of birth have better neurodevelopmental outcomes when compared to 
infants whose cooling commenced between 3 hours and 6 hours (151). Further 
improvements in outcome are highly likely to arise from earlier improved 
identification of affected infants that would allow earlier initiation of treatment after 
resuscitation.  
1.3.4.4 EEG in the immediate newborn period- Preterm Infants 
EEG is also the gold standard for the accurate detection seizures in preterm infants 
(131, 152). However, electrographic seizures are infrequent within the first few days 
of birth in very preterm infants (153). The EEG can also provide real-time markers of 
cerebral dysfunction, even when it is secondary to systemic disease and macroscopic 
cerebral lesions are not evident (154). EEG monitoring of preterm infants in the 
immediate newborn period may have a role in predicting outcomes and furthering our 
understanding of the multiple factors affecting outcome in the immediate newborn 
period. Prediction of outcome following preterm delivery is more complicated than 
following term asphyxia, but investigations are ongoing (155). We now understand 
how brain activity changes over time in preterm infants, and can develop into mature 
healthy EEG patterns over time following preterm delivery (156). Therefore, a 
knowledge of the gestational age of the infant is essential as the EEG varies 
dramatically with maturity (157). 
Accurate neonatal EEG interpretation requires a thorough appreciation of the 
appropriate maturational features for neonates of all gestational ages (GA) as baseline 
EEG patterns evolve in line with the rapid maturational changes taking place in the 
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brain (158). The EEG develops in the most immature neonates at 23/ 24 weeks GA 
through to full-term age with four major trends (156):  
1. Increasing continuity, with defined periods of EEG quiescence for specific 
GAs:  
Early preterm EEG exhibits an intermittent or discontinuous pattern (tracé discontinu) 
consisting of low-voltage activity, known as inter-bursts, followed by short-duration 
higher-voltage activity, known as bursts or spontaneous activity transients (159). This 
pattern differs to the burst-suppression pattern found in the EEG of full-term infants 
following severe brain injury (160). From a physiological perspective, this feature can 
be explained from animal experiments that have shown that the cortex produces 
spontaneous, intermittent activity that is a crucial endogenous driver for the 
development of brain connectivity before cortical networks are modulated by external 
sensory input (161-163). Furthermore, early in development, GABAergic 
transmission is not effectively inhibitory and may allow the generation of these 
endogenous events (164). With the maturation of normal inhibitory GABAergic 
transmission, spontaneous events are gradually abolished and ‘continuous’ 
oscillations emerge at different frequencies due to the increasing influence of 
exogenous sensory driven input (165). Consequently, the overall amount of 
discontinuity decreases and continuity increases with GA. 
Analysis of this discontinuous pattern includes measurements of interburst interval 
(IBI) duration which  decrease with increasing  GA (166) (Figure 1.2). Normative 
values for different GAs have been now reported as follows:  
23- 27 weeks GA: <60 seconds 
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28–29 weeks GA: ≤30 seconds (40 seconds accepted if occasional) 
30–31 weeks GA: ≤20 seconds 
32–34 weeks GA : ≤10–15 seconds 
35–36 weeks GA: <10 seconds 
Aside from the duration of IBIs, their amplitude also changes over time, becoming 
less suppressed with increasing GA (167). 
Figure 1.2 Example of Interburst Interval in infant 26/40 weeks gestation 
 
2. The appearance of sleep cycling 
Differentiation of sleep is detectable in preterm infants <30 weeks GA (168-170). 
Sleep-wake cycling relies on the maturation of interconnected neural networks 
located throughout the cortex, diencephalon and brainstem and is recognisable in 
younger preterm infants because of the influence of deeper brain structures, before 
proper thalamo-cortical connectivity has developed (171-173). In the normal preterm 
EEG, different sleep states and cyclicity are increasingly evident overtime and at 35 
weeks all sleep stages are clearly recognisable (Figures 1.3 and 1.4). 
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Figure 1.3 Example of active sleep with continuous activity in infant 31 weeks 
gestation 
 
Figure 1.4  Example of quiet sleep with discontinuous activity in infant 31 weeks 
gestation 
 
3. Changes in synchrony between hemispheres 
Synchrony in the EEG is present when all EEG features occur simultaneously in 
homologous areas over both hemispheres. Although interhemispheric synchrony has 
been shown to increase with increasing GA, synchronous bursts/IBI activity between 
the two hemispheres is present in preterm infants <30 weeks GA (174, 175). 
Synchrony is an important feature of EEG maturation and reflects the development of 
the corpus callosum and, therefore, the interconnections between the two hemispheres 
(175). Asynchrony decreases with increased maturity, disappearing at term age (175).  
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4. The appearance of several transient waveforms of prematurity.  
Delta activity (0–3.5 HZ), a common background feature < 28 weeks gestation is high 
amplitude, low frequency (0.3–1 Hz) smooth activity organised as unilateral or 
bilateral bursts in centro-occipital or temporal regions, or as short sequences (<80 
seconds) mainly in the occipital regions bilaterally (167). Delta brushes are one of the 
most important features of the preterm EEG. Delta brushes consist of a slow delta 
wave with fast rhythms superimposed (in the alpha-beta range) mainly on the 
ascending slope of the slow wave. They have been reported in all GAs but have a 
peak between 32 and 35 weeks and tend to disappear between 38 and 42 weeks (167). 
Theta activity (4–7.5 HZ), ‘Sharp theta on the occipitals of premature infants’ occur at 
earlier GAs, with a peak at 25 weeks (176).  
Analysis of preterm EEG at a given GA allows for real time monitoring of cerebral 
function and brain health. Several studies have shown that early background EEG 
suppression correlates with severity of periventricular haemorrhage (177-179). The 
most common EEG biomarkers associated with poor outcomes are seizures, positive 
rolandic sharp waves, EEG suppression/increased interburst intervals, mechanical 
delta brush activity, and other deformed EEG waveforms, asymmetries, and 
asynchronies (154).  A continuous display of inter-burst interval duration has been 
cited as a useful prognostic measure in preterm infants in the near future (171, 180).  
Accurate and early prediction of neurodevelopmental outcome in the preterm infant 
provides important clinical information that can be used to guide early intervention, 
assist clinical management, and ensure appropriate long-term needs are identified. 
Predicting outcome at 2 years or more, in the first few days after birth is ambitious 
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however, as preterm infants are vulnerable to brain injury during their entire stay in 
the NICU (181). 
Many studies have attempted to predict short-term outcome. Early clinical 
information, including Apgar scores, gender, birthweight, GA, and illness severity 
scores, such as SNAP-II and SNAPPE-II have been used to predict short-term 
outcome (182-184). Quantitative analysis of multiple risk factors combined in a 
multivariate model can improve outcome prediction (185). Saria et al. showed that a 
combination of quantitative features of early physiological measurements, including 
HR, RR, and SpO2, could predict short-term outcome with a high level of accuracy 
(sensitivity of 86% and specificity of 96%) (186).  Medlock et al. found that 
multivariate models of early clinical information predicted mortality in preterm 
infants better than birthweight or GA alone. Studies implementing the commonly 
used SNAP-II and SNAPPE-II scores showed a range of AUC values for the 
prediction of neonatal mortality, from 0.66 to 0.78 in SNAP-II studies and 0.60 to 
0.91 in SNAPPE-II studies (185). The absence of a reliable measure of neurological 
function, however, may limit the ability of these approaches to predict 
neurodevelopment in the longer term, beyond the early intensive care stage.  
Previous studies have shown that early measurements of EEG can predict long-term 
neurodevelopmental outcome, with high specificity and low sensitivity ranging from 
88 to 96% and 25 to 61%, respectively (187-190). Other studies have shown that the 
amplitude integrated EEG (aEEG) can predict long-term outcome, with specificity 
ranging from 73 to 89% and sensitivity ranging from 56 to 87% (190-192).  
Multimodal prediction models, which include EEG, have shown promise in predicting 
outcome.  A recent study which utilized quantitative analysis of physiological signals, 
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combined with GA and graded EEG, displayed potential for predicting mortality or 
delayed neurodevelopment at 2 years of age (193). In this study infants <32 weeks 
gestation had simultaneous multichannel EEG, peripheral SpO2, and HR monitoring. 
EEG grades were combined with GA and quantitative features of HR and SpO2 in a 
logistic regression model to predict outcome. Bayley Scales of Infant Development-
III assessed 2 year neurodevelopmental outcome. A clinical course score, grading 
infants at discharge as high or low morbidity risk, was used to compare performance 
with the model. While performance of the model was similar to the clinical course 
score graded at discharge, with an AUC of 0.83 (95% confidence intervals (CI): 0.69–
0.95) vs. 0.79 (0.66–0.90) (P  = 0.633), the model was able to predict 2 year outcome 
days after birth. Early EEG grade alone demonstrated low sensitivity (50%) and high 
specificity (89%), compared to clinical course score sensitivity (88%) and specificity 
(70%). The multimodal model which included EEG provided a more balanced 
sensitivity–specificity result (75–74%) (193).  
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1.3.4.5 The rationale for EEG in the immediate newborn period 
EEG is not a new technique but its application in neonatology in the past has been 
hampered by a lack of appropriate technology for recording and analysis. This has 
changed dramatically in the last decade and there are now high quality digital 
amplifiers available that can record excellent EEG signals even in very noisy 
environments. The time is now right to re-explore the use of EEG as a valuable 
biomarker of neurological function in the delivery room; an environment where 
previously, it was just not possible.  
EEG monitoring in the immediate newborn period, for term and preterm infants, 
could provide neonatal teams with valuable, much needed, information about the 
neurological status of the newborn infant, immediately after birth. Following preterm 
delivery EEG monitoring could also enhance our understanding of preterm infant 
outcomes. Thus, a systematic review was performed to assess whether any studies had 
already attempted to measure the human EEG in the immediate newborn period.  
1.3.4.6 Results of a systematic review of EEG in the immediate newborn period 
The initial search identified 215 articles (methodology available section 2.9). After 
assessment of these articles, two original studies were identified that described EEG 
monitoring of the newborn infant within the delivery room (Fig 1.5). One study also 
contributed to a review article identified by our search, which was excluded from our 
study to avoid duplication (95).  Table 1.5 summarises the 2 studies identified. 
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Figure 1.5 Flow Diagram of Literature Search  
 
Pichler et al.  performed a prospective observational study of infants born by elective 
cesarean section over 34 weeks gestational age (105). Infants at lower gestational ages 
were excluded due to concerns about their small head size, and the feasibility in 
applying EEG leads and NIRS to a small surface area. Four gold electrodes (2 frontal 
and 2 parietal) were applied with contact gel, along with a NIRS pad to the left 
forehead, and overlying elastic bandages for support. Amplitude integrated EEG 
(aEEG), a rectified, filtered and compressed form of EEG was acquired and stored. 
Overall they found that aEEG monitoring of the newborn infant in the DR is feasible, 
but it is difficult to obtain continuous reliable data. Of a total number of 63 infants, 17 
(27%) were excluded due to unreliable data. Of the remaining 46 infants, no data was 
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recorded prior to 3 minutes of delivery, 25% had data available at 3 minutes, and just 
over 50% were available at 5 minutes.  aEEG data was analyzed for mean minimum 
and mean maximum voltages every minute, and then correlated with cerebral 
oxygenation, heart rate and pre-ductal oxygen saturations. Findings were then 
compared between infants who were uncompromised at birth (n= 47) and infants who 
required neonatal resuscitation (n=16).  
 
Different cerebral activity patterns were identified between uncompromised newborns 
and those requiring resuscitation. They reported that infants in the uncompromised 
transition group started with initially high voltages on aEEG, followed by a 
significant decrease to baseline voltages at 4-5 minutes. In contrast, infants in the 
group requiring respiratory support did not show this pattern. However, there were no 
significant differences between minimum and maximum voltages when the 2 groups 
were compared, which the authors attribute to low numbers in the respiratory support 
group.  
 
Tamussino et al. recorded simultaneous aEEG and NIRS in 244 term neonates during 
the first 15 minutes after delivery (194).  Similar to the study of Pichler et al.  aEEG 
data was analyzed for mean minimum and mean maximum voltages every minute, 
and then correlated with cerebral oxygenation, heart rate and pre-ductal oxygen 
saturations. Neonates with initial low voltages, which normalized during transition, 
were compared to neonates with normal aEEG values throughout the monitoring 
period. Nine neonates had low initial aEEG voltages and were compared to 50 
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neonates with normal aEEG voltages throughout. Therefore, of 244 infants recruited, 
59 aEEG recordings were included in the analysis. Neonates with initially low 
cerebral activity during immediate transition after birth displayed lower cerebral 
saturations (<10th percentile) on NIRS, but increased cerebral oxygen extraction 
(cFTOE > 90th percentile). The authors concluded that neuro-monitoring with aEEG 
and NIRS might provide useful information on the neonates’ condition during 
immediate transition.  
Table 1.5 Summary of neonatal EEG studies in the immediate newborn period 
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1.3.5 Summary 
The brain is the most vulnerable organ in newborn infants. Birth asphyxia and 
preterm brain injury account for the vast majority of neonatal brain injuries, and are a 
major cause of disability. A non-invasive, continuous method to measure cerebral 
activity (EEG) is already available but it has not progressed to the immediate newborn 
period. As the importance of the early instigation of neuroprotective strategies for 
term newborns with perinatal asphyxia has become evident, EEG monitoring (usually 
aEEG) has become more common in NICUs (195, 196). In contrast to cerebral blood 
flow and NIRS, EEG has well documented applications in the clinical management of 
newborn infants. It is the gold standard method for the accurate detection of all 
neonatal seizures in term and preterm infants (131, 152).  It has well proven efficacy 
in predicting outcomes following perinatal asphyxia, based on patterns of poor 
background activity and the timing of sleep wake cycling reestablishment (143, 197-
199). Prediction of outcome following preterm delivery is more complicated but 
investigations are ongoing (155). This is important as assessing preterm infant 
neurological outcomes is challenging.  
Despite its importance in monitoring the newborn brain in the NICU, EEG monitoring 
in the immediate newborn period is currently not recommended. Stabilisation of 
newborn infants in the delivery room occurs without any objective measure of brain 
activity and we found only two studies that have assessed the feasibility of obtaining a 
newborn EEG recording in the DR. Both studies used the aEEG trend and both found 
it possible to obtain aEEG tracings within 3 minutes in some cases, but obtaining 
continuous reliable data was generally difficult (105). The studies did not include 
infants less than 34 weeks due to technical challenges. Within these limitations the 
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authors describe different patterns in brain activity for infants that required respiratory 
support and infants that transitioned independently. Also, aEEG was correlated with 
different cerebral oxygenation patterns.  
 
Both studies analyzed brain activity by interrogating the aEEG mean minimum and 
mean maximum voltages. However, the aEEG trend alone is a high level summary 
measure of the EEG with poor time resolution due to compression in the aEEG 
algorithm and it does not display the second by second activity of the brain; as a 
result, it is not optimal for application in the DR. Digital aEEG machines obtain one 
or two channels of EEG signal, which is then amplified and passed through an 
asymmetric band-pass filter that strongly attenuates activity less than 2 Hz and more 
than 15 Hz, to minimize artifacts. Additional processing includes semilogarithmic 
amplitude compression, rectification, and time compression (200). Heavy signal 
processing used in the aEEG algorithm eliminates much of the detail (e.g. frequency 
band content) available in the EEG and many clinically important features are lost. 
Furthermore, there is no clear definition for aEEG and most EEG machines 
implement different versions of the aEEG algorithm (201). The mean and maximum 
of the aEEG voltage needs to be plotted and displayed for a number of minutes before 
any assessment of the overall baseline EEG activity can be made. In addition, it is 
well known that interpretation of the background aEEG pattern can be problematic 
due to baseline drift and other artefacts (202, 203). This is not optimal for DR EEG 
recording when real-time second by second information would be advantageous. For 
example, a recording of approximately 30 seconds duration alone using standard EEG 
would be enough to establish the presence of continuous EEG activity in a term 
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newborn. This information would be hugely beneficial in the DR to help guide 
resuscitation and to determine the need for immediate passive cooling. Thoresen et al 
coined the phrase ‘time is brain’ in relation to the timing of cooling for 
neuroprotection (151).  
EEG in its raw format (not a modified aEEG) can be assessed both qualitatively and 
quantitatively. Qualitative EEG analysis is mainly used for clinical purposes. It is 
based on visual interpretation of the EEG signal and describes background features 
such as amplitude, frequency, and continuity of the EEG, symmetry, synchrony, and 
sleep–wake cycling. Quantitative EEG analysis is a method predominantly used in 
research and includes time and frequency domain analysis. Neither study identified in 
our review analyzed the EEG in its raw format, either for qualitative or quantitative 
purposes.  
 
EEG has long been considered just too difficult to deploy in environments like the DR 
and NICU. There have been major recent advances to the adoption of EEG in the 
NICU primarily due to advances in technology (204). The application of EEG in 
preterm infants has also progressed, and many technical barriers overcome (205). 
Modern machine learning techniques are also advancing rapidly and will soon be able 
to provide non-EEG experts with the help needed to assist in the interpretation of 
EEG patterns on a 24/7/365 basis. These difficulties should no longer be a barrier to 
the adoption of EEG in the immediate newborn period.  
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In conclusion, the time is now right to advance the objective monitoring of 
neurological function of newborn infants in the immediate newborn period, and 
specifically brain activity, measured by EEG.  
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Chapter 2   
General methodology 
 
2.1 Introduction 
This chapter provides an outline of the general methods used in the studies described 
in this thesis. The chapter describes how and where the patients were recruited, the 
devices used, data collection and storage, and the statistical methods used to analyze 
the data. Other specific methods used in certain studies presented in this thesis are 
outlined in the relevant chapters.  
 
2.2 Subjects and Settings  
This research was performed in the delivery room and neonatal unit of the Cork 
University Maternity Hospital (CUMH). This is a level three maternity unit with up to 
8500 deliveries per annum. Infant cohorts were recruited between July 2015 and 
January 2017. 
 
2.3 Patient Recruitment  
Antenatal recruitment was used for all studies. For studies in term infants (Chapters 3 
and 4), recruitment occurred during daytime working hours as all infants included 
were delivered by elective caesarean delivery. Recruitment for preterm infants 
(Chapter 5) was more challenging as they are by nature emergency deliveries. 
Therefore, a number of measures were taken to optimize patient recruitment. Firstly, 
the medical and nursing staff of the neonatal unit and the obstetric and midwifery 
staff in the labour ward were informed of the study, its aims and recruitment criteria. 
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Laminated posters stating the recruitment criteria were placed in the NICU, the labour 
ward, antenatal ward, and medical staff on- call rooms (Figure 2.1). All staff were 
encouraged to contact me if there was a possibility of a preterm infant being  
delivered < 32 weeks gestation. There was a dedicated research phone which could be 
contacted 24/7. This phone was carried by me or by one my research colleagues, AP 
and DHR. AP and DHR were Clinical Research Fellows in the INFANT Research 
Centre in CUMH and were both ethically approved to consent and randomize infants 
for this trial.  
 
Figure 2.1 Poster for Preterm Infant Trial 
 
 
Despite these measures a number of challenges to recruitment persisted. The time 
period prior to delivery is a stressful time for parents. It is difficult to find an 
appropriate time where a sensitive and thorough antenatal consent consult can be 
performed. The clinical needs of the mother always took precedence, and parents 
were only approached if there was adequate time for consultation, and parents were 
happy to proceed. It was a priority that all parents were fully informed and had read 
the appropriate parent information leaflet before consenting. Many deliveries during 
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the study period occurred under emergency circumstances and it was not possible for 
a researcher to attend in a timely fashion.  Flow diagrams detailing patient recruitment 
are available in the relevant chapters.  
 
2.4 The Consent Process  
For trials in term infants parents were approached on the day of admission prior to 
elective caesarean delivery. For trials in preterm infants parents were approached 
where possible on the antenatal ward or in the case of imminent delivery on the labour 
ward.  
The reasons, the risks and the benefits for the study were explained to both parents. 
Any concerns relating to the study were also discussed with the parents. It was 
emphasized that the current study might not be of any benefit to their infant but that 
the data collected could be an important source of information in our quest to improve 
care and survival of infants in the future.  
 
A written detailed information leaflet explaining each study and outlining the 
rationale for doing such research was provided to the parents. The information leaflet 
also mentioned any potential risks and benefits. The information leaflet was for 
parents to keep and to read in their own time if they needed time to make up their 
mind on whether to participate or not. Along with the information leaflet, parents 
were given a consent form that they could sign if they agreed to participate in our 
study. Both documents are included in the Appendices.  
 
Parents were given an opportunity to think about the information provided, and opt in 
or out of participation in the study as they wish and at any stage of the study. It was 
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also made clear that they could opt out of the study at any later time and that any data 
that had been collected would be deleted. Parents who agreed to participate in the 
study were given a copy of the signed consent form as evidence of the agreement to 
participate in the study. 
 
2.5 Ethics  
Ethical permission to carry out all studies was obtained from the Clinical Research 
Ethics Committee (CREC) of the Cork University Hospital Teaching Hospitals prior 
to study commencement. The ethics acceptance letter and consent forms and parent 
information leaflet are provided in the Appendices.   
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2.6 Infant monitoring 
2.6.1 EEG monitoring 
2.6.1.1 EEG devices 
For term infants included in this thesis, all recordings were performed and stored 
using the Unique EEG system (Inspiration Healthcare, Leicester, UK). For preterm 
infants, recordings were obtained either with the NicoletOne (CareFusion Co., San 
Diego, USA)(Figure 2.2) or Moberg (Moberg Research Inc., PA, USA) EEG systems.  
 
Figure 2.2 Nicolet 1 EEG operating system  
 
 
2.6.1.2 EEG application 
A member of the research team performed all EEG studies following a standardized 
protocol. For term infants the aim was to capture brain activity as soon as possible 
after birth. All EEG recordings were obtained in the DR as soon as possible after 
birth.  For preterm EEG was applied in the DR or in the NICU. When EEG was 
applied in the DR, recordings were commenced at that time, were discontinued during 
transfer to NICU and commenced again on arrival to NICU.  
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For term infants the infants’ scalp was first cleaned using an alcohol wipe. As per 
usual clinical practice previously described in our NICU, the hair was then parted at 
EEG sensor sites, and the skin gently abraded three to four times using a sterile cotton 
bud and skin preparation gel (Nuprep)(205). Six sterile disposable flat surfaced EEG 
electrodes were then attached to the infants’ scalp over frontal and central regions 
(F4, C4, F3, C3, ground, and reference) bilaterally using the 10-20 system of 
electrode placement and the EEG was recorded for up to ten minutes. Two channels 
of a bipolar recording were displayed (F4-C4, F3-C3) on the monitor. The study was 
designed to obtain 2 channels as applying more electrodes would have delayed the 
onset of recordings. 
 
The method for electrode placement in preterm infants in our unit has previously been 
described (205). Depending on infant size, 4- 11 electrodes were positioned according 
to the international 10–20 system of electrode configuration over the frontal, central, 
temporal, and occipital regions, a reference electrode at Fz, and a ground electrode 
behind the left ear (Figure 2.3). Although the aim was to obtain as many channels of 
EEG as possible, infant stability and the length of time to apply extra electrodes was 
taken into account at all times.  
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Figure 2.3 Example of EEG electrode placement in a preterm infant 
 
 
 
2.6.1.3 EEG data collection and analyses  
EEG data was sampled at 256 Hz and stored on computer hard disk for off-line 
anlysis. Firstly, the recordings were assessed for quality and periods of artefact-free 
EEG were identified for analysis.  All EEG recordings for term infants were initially 
anotated for 3 minute artefact free segments. All EEG recordings for preterm infants 
had one hour segments at 6 and 12 hours annotated.  They were then visually 
analyzed by GBB for quality, overall voltage, continuity and frequeny (206). 
Annotated segments of EEG were then analysed for quatitative measures. Different 
quantitative measures for term and preterm recordings were applied and are described 
in the relevant chapters.  
 
 All quantitative measures were performed using the software package NEURAL, a 
neonatal EEG feature set in matlab (v0.3·0), which runs within the Matlab 
environment (The MathWorks, Inc., Natick, Massachusetts, United States). NEURAL 
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was developed to standardize quantitative analysis of newborn EEG by including full 
implementation details(206).  
 
Quantitative EEG analysis provides an alternative to visual interpretation, and 
provides consistency without the varying degrees of inter-rate agreement associated 
with visual interpretation. Quantitative analysis can also uncover attributes not 
accessible with visual analysis alone, and can facilitate reproducible research for 
clinical and scientific studies.  
 
2.6.2 NIRS monitoring  
The INVOS 5100 near infrared spectrometer (Somanetics Corporation, Troy, MI, 
USA)(Figure 2.4) was used to measure rcSO2. A NIRS neonatal probe, OxyAlertTM 
NIRSensor (Covidien IIc, Mansfield, MA, USA) was applied in a fronto temporal 
location (Figure 2.5). The INVOS machine recorded and stored rcSO2 throughout the 
DR and NICU periods with a sampling period of five and six seconds. This device’s 
rcSO2 measurements are limited to a specific lower and upper limit of 15% and 95% 
respectively, therefore no measurements below 15% and above 95% can be measured 
(207). 
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Figure 2.4 INVOS NIRS System 
 
 
 
Figure 2.5 OxyAlert TM NIRS sensor 
 
 
 
2.6.3 Respiratory function monitoring 
A Respironics NM3 Monitor (Philips, Amsterdam, Netherlands)(Figure 2.6) was 
used, which is a non-invasive respiratory function monitor with combined mainstream 
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capnography and flow monitoring (Capnostat 5 sensor, Philips, Amsterdam, 
Netherlands). The dead space volume as reported by the manufacturer is ~ 1 ml. The 
CO2 / flow sensor was attached to a facemask (Laerdal infant mask; Stavanger, 
Norway) and placed over the infants’ mouth and nose on arrival to the resuscitator. 
End tidal CO2 was measured by infrared absorption spectroscopy, while RR, TVs, and 
airway pressures were measured by a gas flow sensor (Capnostat 5 sensor). 
 
  Figure 2.6 Respironics NM3 Monitor 
 
2.6.4 Echocardiography 
Echocardiographic measurements were performed using the GE Vivid I ultrasound 
machine (KPI Healthcare, CA, USA). Measurements were taken to assess systemic 
blood flow, by superior vena cava (SVC) flow (ml/kg/min), right ventricular output 
(208) (ml/kg/min), and left ventricular output (LVO)(ml/kg/min). All measurements 
were performed by a member of the research team following a standardized protocol 
previously described (209).  
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2.7 Delayed cord clamping with bedside resuscitation  
Delayed cord clamping with bedside resuscitation was the experimental interventional 
arm in the preterm infant trial which will be described in detail in chapter 5. A mobile 
resuscitation trolley (Lifestart, Inspiration Healthcare, UK)(Figure 2.7) designed 
specifically to facilitate newborn bedside  resuscitation, with an intact cord was 
introduced to CUMH. 
A key element in the design is flexibility to allow the baby to be placed on the trolley 
while the umbilical cord is still intact. This required the trolley platform to be easily 
manoeuvrable.  Thermal support is provided by the CosyTherm electric heated 
mattress. Fixed around the central pillar are two universal Medirails which 
accommodated a Tom Thumb Infant Resuscitator (Viamed, Keighley, UK), oxygen 
blender (Inspiration Health Care Ltd., Leicestershire, UK), a suction bottle driven by 
the wall-supplied air supply (Oxylitre Ltd., Manchester, UK) and the control unit for 
the CosyTherm heated mattress (Inditherm, Rotherham, UK). It was connected with 
hoses to the air and oxygen wall supply. Infants were placed on a mobile resuscitation 
trolley with the cord intact, and at or below the level of the placenta. Routine neonatal 
care was provided and the cord clamped at 60 seconds following delivery. 
Figure 2.7 Lifestart bedside resuscitation trolley 
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2.8 Statistical analysis  
SPSS version 22, and PROC MIXED in SAS, version 9.4 (SAS Institute Inc., Cary, 
NC, USA) were used along with the Matlab programming environment to perform 
statistical tests. Patient characteristics were compared using the t-test or Mann-
Whitney U test, as appropriate. A p-value <0.05 was considered to be statistically 
significant. Specific statistical models are described in detail in the relevant chapters.  
 
2.9 Search Strategy and Study selection for Systematic review- EEG in the 
Immediate Newborn Period 
A systematic stepwise search of PubMed was performed as per the Preferred 
Reporting Items for Systematic Reviews and Meta- Analyses (PRISMA) (210). 
Articles up to and including February 2017 were included. Studies had to involve 
EEG monitoring in the DR. Search terms included: infant, newborns, neonate, 
delivery room, afterbirth, transition and electroencephalography. Only human studies 
were included and this was incorporated into the initial search. Additional published 
reports identified in review articles, or referenced in articles screened were also 
included.  
 
Articles identified by our search strategy were screened for inclusion by one author 
(211). Titles and abstracts were initially screened. Articles had to pertain to EEG 
monitoring immediately after birth. Studies that focused on infants post birth 
asphyxiation or infants who had intra cranial pathology were excluded as the subjects 
were, by nature, recruited post-delivery and not relevant to our search. Studies that 
specified a time frame for initial EEG monitoring outside of the first fifteen minutes 
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of life, or initial recruitment outside of the delivery room were also excluded.  Where 
uncertainty remained regarding eligibility for inclusion the full text was reviewed. 
Studies that were not available in English were excluded.  
 
2.10 Work undertaken for this MD 
I was the lead clinical research fellow on all studies included in this thesis. I worked 
with my supervisors, EMD and GBB, in designing each study. I obtained ethical 
approval from University College Cork for the studies described in Chapters 3 and 5, 
and designed the consent and parent information leaflets. I registered the randomized 
controlled trial CUPID which is described in Chapter 5 with an international registry. 
I led the recruitment phase for each study and obtained the majority of informed 
ethical consents for all studies, and when I was not available members of the INFANT 
research team (EMD, DRH, AP, JDM) obtained consent.  
I performed data collection in all studies:  
Chapter 2: I performed the systematic review of EEG in the immediate newborn 
period.  
Chapter 3: I performed all EEG studies. 
Chapter 4: I performed 50/100 respiratory function monitoring. Fifty patients 
recruited had monitoring performed by research team members JDM and LD.  
Chapter 5: I introduced delayed cord clamping with bedside resuscitation to CUMH. 
This involved liaising with obstetricians, neonatologists, theatre nurses, midwives, 
neonatal nurses, infection control and clinical engineering. I designed standard 
operating procedures for the use and maintenance of the resuscitation trolley.  I 
trained all necessary staff in the use of the mobile resuscitation trolley.  I performed 
bedside resuscitation in the majority of infants randomized to delayed cord clamping. 
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I performed the EEG, NIRS and echocardiography in the majority of patients. When I 
was not available EEG and NIRS was performed by research team members (AP, RL, 
CA, EP, LK) and echocardiography by EMD.  
IH research nurse aided in the recruitment and data collection for all studies.  
 
I collected the data for each study and performed initial data analysis. I was aided in 
the analysis of data. JOT performed quantitative analysis of EEG and NIRS data for 
all studies. GBB performed visual analysis of EEG data. VL aided with all statistical 
analysis. I interpreted the data for all studies, and drafted the initial manuscripts for 
each study.  The manuscript for each study was reviewed by all authors who are listed 
on pages 18-20. I drafted the manuscript for this thesis which has been reviewed, 
edited and approved for submission by GBB, and EMD.  
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Chapter 3 
Respiratory Adaptation in Term Infants following 
Elective Cesarean Section 
3.1 Introduction 
In the next chapter brain activity in the first minutes of life will be discussed. 
However, it is important to first explore newborn respiratory adaptation. Our 
understanding of newborn respiratory adaptation is the result of many innovative 
clinical trials and collaborative efforts over the past 60 years (212-219). Lung aeration 
and the establishment of functional residual capacity (FRC) is critical in newborn 
transition from fetal life (212).  
  
In recent years, technological advances in neonatal monitoring have facilitated real 
time monitoring of physiological parameters during newborn transition (220, 221). As 
previously described, Dawson and colleagues produced centile charts detailing the 
normalisation of oxygen saturations over time during newborn adaptation (27). More 
recently Schmolzer and colleagues utilized respiratory function monitors (RFM) to 
document exhaled CO2, and tidal volumes (TV) for term infants immediately after 
vaginal deliveries (222).  
 
However, gaps in our understanding of newborn adaptation remain.  Respiratory 
function monitoring values in infants born by ECS and thus not exposed to the 
mechanical and hormonal adjustments that occur during labour and vaginal delivery 
have not been reported. The aim of this study is to define newborn physiological 
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ventilation parameters (RR, TV, EtCO2) over the first minutes of life in healthy term 
infants following ECS, and also to assess the time at which these parameters stabilise.  
 
3.2 Methods 
3.2.1 Study participants 
Infants > 37 weeks’ gestational age, born by ECS, were eligible for inclusion in the 
study. Infants with major congenital abnormalities affecting newborn respiratory 
adaptation were excluded. Infants requiring intervention to support stabilisation 
beyond being warmed, dried, and stimulated, or Apgar scores < 7 at 1 minute were 
also excluded from the study.  
 
3.2.2 Data acquisition 
Following delivery, infants were brought immediately to a Panda Resuscitator (GE 
Healthcare, Laurel, MD, USA) which has a continuous-flow, pressure-limited, T-
piece device with a built-in manometer and a PEEP valve. A  Respironics NM3 
Monitor (Philips, Amsterdam, Netherlands) was used, which is a non-invasive 
respiratory function monitor with combined mainstream capnography and flow 
monitoring (Capnostat 5 sensor, Philips, Amsterdam, Netherlands). The dead space 
volume as reported by the manufacturer is ~ 1 ml. The CO2 / flow sensor was attached 
to a facemask (Laerdal infant mask; Stavanger, Norway) and placed over the infants’ 
mouth and nose on arrival to the resuscitator. Each infant was monitored for up to 10 
minutes. End tidal CO2 was measured by infrared absorption spectroscopy, while RR, 
TVs, and airway pressures were measured by a gas flow sensor (Capnostat 5 sensor).  
All infants included in the study were breathing spontaneously without additional 
flow or oxygen. As all infants were born by cesarean section, monitoring did not 
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interfere with skin-to-skin time or initiation of breastfeeding. Follow up RFM was 
performed, where appropriate, for 2 minutes at 2 hours of age using the same RFM. 
All measurements were performed by one of the research team following a 
standardized protocol. Each infant was video recorded during study measurements. 
Recordings were commenced once an infant’s whole body was delivered and captured 
infants once they were placed on the resuscitaire. This allowed for future accurate 
documentation of the age (in seconds) when monitoring commenced. There is no 
hospital protocol on the timing of umbilical cord clamping following ECS, and timing 
of clamping was not influenced by this research study. The time of cord clamping was 
not recorded. Maternal and infant demographics were recorded. 
 
3.2.3 Data Collection and Statistical analyses  
For the duration of each recording a breath-by-breath analysis was exported from the 
Respironics NM3 Monitor (Philips, Amsterdam, Netherlands) to SAS, version 9.4 
(SAS Institute Inc., Cary, NC, USA).  Respiratory rates, TV, inflation time, and 
EtCO2  means were calculated for each minute of the recording, starting from time of 
birth. In the initial study design the aim was to record all infants for the first ten 
minutes of life. However, the practical needs requiring infants to be weighed, dressed 
and brought to their parents within the time constraints of a busy obstetric theatre led 
to many recordings being terminated early. Breaths were excluded if mask leak was 
>30%. At each minute time point, the data for the features were summarized 
descriptively using the number of observations (n), mean and standard deviation 
(223).  
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To investigate how each feature (RR, TV and EtCO2) changed over time, a mixed 
modeling approach was used. The optimal functional form of the trajectory over time 
was identified by considering the family of polynomial functions (a straight line, a 
quadratic curve and a cubic curve), and identifying the best fitting model (224). A 
bottom-up strategy was used, beginning with an empty random intercepts model (no 
fixed effects and individual as a random effect) and then adding each fixed time effect 
(linear, quadratic, cubic), followed by its corresponding random time effect  (linear, 
quadratic, cubic), in turn (225). Likelihood ratio tests were used to compare the 
difference between the deviance statistics across consecutive models to test the impact 
of each new term. Model fit was evaluated using the deviance statistic (-2 log 
likelihood) and the Akaike Information Criterion (AIC). For each feature, the 
predicted values from the best-fitting mixed model and their corresponding standard 
errors were used to construct a 95% reference range, assuming a normal distribution. 
For all analysis, time was centred at one minute (start of study). To investigate if 
changes over time differed by admission group (admitted/not admitted), the fixed 
effects of admission group and the interactions of admission group by time (linear, 
quadratic and cubic, as appropriate) were added to the mixed model. Pearson’s 
correlation coefficient was calculated between RR, TV and EtCO2 for each time point 
and between the first minutes of EtCO2 and the 2-hour values. All statistical analysis 
was performed using PROC MIXED in SAS, version 9.4 (SAS Institute Inc., Cary, 
NC, USA). All tests were two-sided and a p-value <0.05 was considered to be 
statistically significant. 
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3.3 Results 
 
3.3.1 Study Participants 
One hundred and four infants born by ECS at term were recruited. Ninety-five infants 
were included in the analysis (Figure 3.1). One infant was excluded due to unexpected 
congenital malformation noted following delivery, and one infant due to the need for 
positive pressure ventilation (PPV) during newborn stabilisation. The Respironics 
RFM stored measurements sequentially for each infant breath. However, for seven 
infants, measurements were not automatically saved from the beginning of the 
recording and the timing of subsequent values recorded could not be fully ascertained. 
Therefore, these infants were excluded from the data analysis. The median (IQR) 
gestation was 39 weeks (38.2- 39.1) and median (IQR) birth weight was 3420g (3155-
3740).  Forty-seven (49%) infants were male. Indication for ECS were; prior 
caesarean section n=81 (85%), breech presentation n= 8 (8%), prior traumatic vaginal 
delivery n=5 (5%), IVF pregnancy n=1 (1%).  Median time from birth until initiation 
of monitoring was 26.5 (range: 20-39) seconds.  Nine infants were admitted to the 
NICU. The discharge diagnosis for all nine infants was transient tachypnea of the 
newborn (226).  
 
 85 
Figure 3.1 Flow Diagram  
 
 
 
 
3.3.2 Measures of TV, RR and EtCO2 
It was intended for measurements to be performed on all infants (n=95) for the first10 
minutes of life. However, for practical reasons many recordings were terminated early 
and values are not reported beyond the first seven minutes of life. The mask was 
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removed and replaced on a number of occasions for each baby due to loss of seal, 
movement of newborn and/or  presence of secretions. These values (12% of all 
breaths) were omitted from the analysis and the mixed model effect analysis was 
utilised to account for these over time.  
 
Descriptive statistics for RR, TV and EtCO2  at each time point are presented in Table 
3.1. Mean RR increased for each time point between 1 minute (44.31) and 7 minutes 
(61.62) of life. Mean TV increased over the first 3 minutes (5.18mls/kg- 6.44mls/kg) 
and then decreased over time (5.07mls/kg at 7 minutes). Mean EtCO2 measurements 
also increased over the first 3 minutes (4.32kPa-5.64kPa) and then stabilised (5.74kPa 
at 7 minutes). The mixed modelling approach found that the trajectories for mean RR, 
TV and EtCO2 changed significantly over the first minutes of life. The best fitting 
models included fixed cubic time effects and random cubic time effects for TV and 
EtCO2 and a fixed quadratic time effect and a random quadratic time effect for RR. 
Trends over time can be appreciated in Figures 3.2, 3.3, and 3.4. 
 
Table 3.1 Descriptive statistics of features at each time point  
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Figure 3.2 Respiratory Rate (breaths per minute) between 1 and 7 minutes after 
birth 
 
 
Figure 3.3 Tidal volume (mls/kg) between 1 and 7 minutes after birth 
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Figure 3.4 EtCO2 (kPa) between1 and 7 minutes after birth 
 
 
 
3.3.3 Correlations between RR, TV and EtCO2  
Pearson’s correlation coefficients between pairs of features were calculated for each 
time point (minutes 1-7 separately). TV and EtCO2 are positively correlated, whilst no 
correlation between TV/RR nor EtCO2/RR exist.  
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3.4 Discussion 
This study describes changes in RR, TV and EtCO2 over the first minutes following 
elective cesarean section in a large number of healthy term infants. Following 
delivery, the trajectories of TV and EtCO2 correlated, with both increasing over the 
first 3 minutes before stabilizing. This is important, as median (IQR) age at time of 
initial EEG recordings in Chapter 3 was 3.0 (2·5 to 3·8) minutes. This implies that 
functional residual capacity had been established for the majority of infants when 
brain activity was measured, and that the values reported represent brain activity at a 
time when respiratory adaptation has been achieved. It was also noted that respiratory 
rates increased continuously from birth until recordings ceased.  
 
Over the past 50 years a number of novel studies have informed our understanding of 
how newborn infants’ clear fluid from their lungs and establish FRC to facilitate gas 
exchange (213, 216, 218, 227, 228).  Schmolzer et al performed RFM in 20 term 
infants during the first 2 minutes of life following vaginal delivery (222). They found 
that FRC is partially established soon after delivery and exhaled CO2 can be detected 
within 1-8 breaths after birth. Similar to our findings, CO2 levels were closely 
associated with TVs and increased as FRC was established over the first few minutes. 
Similar absolute values for TV and EtCO2 are also reported in their study, but peak 
levels were reached earlier in their cohort of infants following vaginal delivery. End 
tidal CO2 peaked at 3 minutes in our cohort at mean values of 5.69kPa, whilst 
Schmolzer et al reported exhaled CO2 values of 5.73kPa at 2 minutes. Tidal volumes 
of 6.3ml/kg were reached at 2 minutes in Schmolzer’s cohort. Similar volumes (when 
corrected for mean weights) were reached at 3 minutes in our infant cohort.  These 
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findings are not surprising, as previous studies have described variations in transition 
between infants born by cesarean section and vaginal delivery (215, 219).   
 
Newborn transition begins prior to delivery for infants born following spontaneous 
vaginal labour (229)(230).  Functional residual capacity was established later in 
infants following cesarean section compared with vaginally delivered infants in 
studies using plethysysmography (215). Our findings in infants born by cesarean 
section support this work. Increased interstitial pulmonary fluid in these infants may 
delay the establishment of FRC and time to reach optimum gas exchange levels. 
However, our cohort had peak levels of EtCO2 at 3 minutes whilst Palme-Kilanders’ 
cohort of infants born by caesarean section had increasing levels of CO2 over the first 
5 minutes, which is delayed compared to our findings. Comparisons between 
historical studies may not be appropriate as they all had small study numbers, high 
levels of intervention in the DR, and relied on chart based analog equipment 
compared to current digital RFM. It also highlights the importance of having 
documented respiratory adaptation in a cohort of infants following ECS in order to 
interpret newborn brain activity following ECS.  
 
RRs increased continuously over time during our study and plateau levels were not 
captured during the first 7 minutes. However, respiratory patterns were not studied, 
and may be more important than the actual rate. Different respiratory patterns such as 
expiratory braking, which is common in newborn infants occurs when expiratory flow 
is followed by a period of low or absent flow and results in short or multiple 
expiratory flow peaks (212).   
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This study has a number of limitations. The Respironics RFM recorded values on a 
breath-by-breath basis, which allowed for accurate documentation of values and to 
monitor the progression of physiological parameters over time. However, an intrinsic 
error within the monitoring system resulted in the monitor failing to record all 
measurements, with up to 3% of breaths being missed in an individual baby. A mixed 
model analysis was performed to allow for missing data entries. The mixed model has 
the advantage over other statistical tests (such as a repeated one way ANOVA) as it 
uses all available data, and infants are not excluded from the analysis if they are 
missing data at some of the time points. However, seven infants were excluded as 
initial breaths were not recorded and the timing of the values that were recorded could 
not be ascertained. Also, many recordings were terminated early for practical reasons 
and we were unable to report findings beyond the first seven minutes of life. These 
limitations highlight the challenges in performing such studies in the immediate 
newborn period. It must also be noted that monitoring is associated with additional 
dead space, which may theoretically increase the work of breathing and confound 
results.   
 
In conclusion, this study documents for the first time values for RR, TV and EtCO2 
during newborn transition following elective cesarean section in a large cohort of 
healthy term infants. These findings provide valuable information pertaining to 
physiological respiratory parameters during newborn transition to extrauterine life 
following elective cesarean section.  
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Chapter 4 
EEG for the Assessment of Neurological Function of 
Term Infants in the Immediate Newborn Period 
 
4.1 Introduction 
Neonatal electroencephalography (EEG) monitoring has well documented 
applications in the management of infants with hypoxic ischemic encephalopathy 
(HIE) (131, 231-234). EEG is essential for the diagnosis of neonatal seizures (200, 
235, 236). Hypoxic ischemic encephalopathy is a leading cause of neonatal death and 
long-term neurological disability, with an estimated incidence of 1·5 per 1000 live 
births (237). Therapeutic hypothermia (TH) is now the standard treatment for infants 
with moderate or severe HIE, and results in a significant reduction in mortality, 
without an increase in major disability amongst survivors (238). The optimal timing 
to commence TH is within 6 hours of birth and thus eligibility for TH should be 
decided as soon as possible (239, 240). 
 
Information about newborn electrocortical activity to date is almost exclusively based 
on EEG recordings performed after six hours of age, or occasionally from around 
three hours in infants that are unwell (241, 242). Infants are stabilised in the delivery 
room following potentially severe hypoxic ischemic events without objective 
information about brain activity. Clinical assessments of newborn wellbeing are 
limited and liable to inter and intra rater variability (15, 16). Therefore, the 
introduction of EEG monitoring in the immediate newborn period may be a useful 
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adjunct in certain circumstances. The first step in evaluating its use is to assess 
whether it is feasible to perform, and if so, to establish normative reference values.  
 
This study assesses qualitative and quantitative features of the EEG during newborn 
transition and aimed to produce reference values for healthy term infants during this 
vulnerable time period. 
 
4.2 Methods 
 
4.2.1 Study participants 
Infants born in Cork University Maternity Hospital, Ireland were recruited over two 
months between September- October 2015. Infants > 37 weeks’ gestational age, born 
by elective caesarean section (ECS), were eligible for inclusion in the study. Infants 
with major congenital abnormalities were excluded. Infants requiring intervention to 
support stabilisation beyond being warmed, dried, and stimulated, or with Apgar 
scores < 7 at one minute were also excluded from the study. 
 
4.2.2 EEG acquisition  
Following delivery, infants were brought immediately to a Panda Resuscitator (GE 
Healthcare, Laurel, MD, USA). All EEG studies were performed by DF following a 
standardized protocol. The infants’ scalp was first cleaned using an alcohol wipe. As 
per usual clinical practice previously described in our NICU, the hair was then parted 
at EEG sensor sites, and the skin gently abraded three to four times using a sterile 
cotton bud and skin preparation gel (Nuprep)(205). Six sterile disposable flat surfaced 
EEG electrodes were then attached to the infants’ scalp over frontal and central 
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regions (F4, C4, F3, C3, ground, and reference) bilaterally using the 10-20 system of 
electrode placement and the EEG was recorded for up to ten minutes. Two channels 
of a bipolar recording were displayed (F4-C4, F3-C3) on the monitor. All recordings 
were performed and stored using the Unique EEG system (Inspiration Healthcare, 
Leicester, UK). Each EEG study was video recorded and recordings commenced after 
delivery of the infant. This allowed for future accurate documentation of infant age 
(in seconds) when monitoring commenced, and to correlate recordings with infant 
movements and newborn care. As all infants were born by caesarean section, 
monitoring did not interfere with skin-to-skin time or initiation of breastfeeding.  
Maternal and infant demographics were recorded, including type of anaesthesia used 
and Apgar scores.  Newborn admissions to the NICU, and discharge diagnosis on 
chart review were also documented.  
 
4.2.3 Data Collection and analyses  
EEG data was sampled at 256 Hz and stored on computer hard disk for off-line 
analysis. All EEG recordings were visually analyzed. Firstly, the recordings were 
assessed for quality and periods of artefact-free EEG were identified for analysis.  
The EEG was then assessed for overall voltage, continuity, frequency, and maturity.   
 Three minutes of artefact-free continuous EEG segments were then selected from 
each infant’s recording for quantitative analysis. All quantitative measures were 
performed using the software package NEURAL, a neonatal EEG feature set in 
matlab (v0.3·0), which runs within the Matlab environment (The MathWorks, Inc., 
Natick, Massachusetts, United States). NEURAL was developed to standardize 
quantitative analysis of newborn EEG by including full implementation details (206), 
and is freely available as open-source software 
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(https://github.com/otoolej/qEEG_feature_set).  Quantitative measures that capture 
amplitude and frequency characteristics were used. Features of spectral power were 
calculated within 4 frequency bands, to quantify specific activity at delta (0·5-4 Hz), 
theta (4-7 Hz), alpha (7-13 Hz), and beta (13-30 Hz) bands.  
 
Features reported are: 
 Total and relative spectral power for the four frequency bands.  
 Range-EEG (rEEG): median, lower and upper margins, and asymmetry(243).  
 Spectral edge frequency and fractal dimension over the total 0·5-30 Hz 
frequency band.  
A comprehensive description of each measure, including implementation details, is 
available in reference (206). Spectral power and rEEG features capture amplitude 
characteristics of the EEG; spectral edge frequency and fractal dimension features 
capture the spectral characteristics. The edge frequency estimates the extent of 
spectral spread: higher values indicating a more disperse spectrum and lower values 
indicating a more condensed spectrum around the lower frequencies. Fractal 
dimension captures the shape of the spectrum.  Within a frequency band, typically 
0·5-30 Hz, neonatal EEG is known to follow a spectral power law, with a linear log-
log spectral relation defined as , where α represents the slope of  
spectrum (244). The fractal dimension estimate D provides an estimate of this slope, 
as  (245). 
 
Range-EEG (rEEG) gives a measure of peak-to-peak voltage (243). rEEG was 
proposed as an alternative to amplitude-integrated EEG (aEEG) as there is no clear 
definition of aEEG and most EEG machines implement different versions of the 
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aEEG algorithm (246). A 1-20 Hz bandpass filter was applied to the EEG before 
generating the rEEG.  
 
All features, except for the rEEG, are computed on a 32 second epoch of EEG with a 
50% overlap. The median value over all epochs is used to summarize the feature. The 
median value is also used to summarize across the two channels.  
 
Mean values, standard deviation, minimum, and maximum values were used to 
describe symmetrical data. Median, interquartile range, minimum and maximum 
values were reported on non-Gaussian data.  
 
4.3 Results 
 
4.3.1 Study Participants 
Fifty- two infants born by ECS at term were recruited.  Forty-nine infants were 
included in the analysis.  Three infants were excluded: one infant due to unexpected 
congenital malformation noted following delivery, one infant due to the need for 
positive pressure ventilation during newborn stabilisation, and another infant due to 
insufficient length of recording because of technical difficulties during recording.  
Thus, 49 infants were included in the analysis (Figure 4.1). The median (IQR) 
gestation was 39 (38·7 to 39·1) weeks and median (IQR) birth weight was 3500 (3245 
to 3742) g. Twenty-nine (59%) infants were male. Indication for ECS were prior 
caesarean section in the majority of cases n=43 (88%), breech presentation n= 2 (4%), 
prior traumatic vaginal delivery n=2 (4%), and maternal reasons 2(4%). Two 
caesarean sections were performed under general anaesthesia and the remaining 47 
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under spinal anaesthesia (morphine, and fentanyl). Median (IQR) age at time of initial 
EEG recording was 3.0 (2·5 to 3·8) minutes. No infant was compromised at birth. 
Five infants were admitted to the neonatal unit. The discharge diagnosis for all five 
infants was transient tachypnea of the newborn, and all infants were discharged within 
the first three days of birth. Infant characteristics are summarised in Table 4.1 
 
Figure 4.1 Flow diagram  
 
Table 4.1 Infant characteristics 
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4.3.2 Visual analysis 
Good quality continuous and symmetric mixed frequency EEG activity, appropriate 
for gestational age was seen in all infants with a range of 25-50µV, see example in 
Figure 4.2. Movement artefact contaminated many recordings but continuous EEG 
activity without artefact was measurable for a minimum of 3 minutes in all infants.  
 
Figure 4.2 Example EEGs from 2 infants 
 
 
 99 
4.3.3 Quantitative analysis 
Quantitative features are summarized in Table 4.2. Total power decreased at the 
higher-frequency bands:  median (IQR) relative delta power of 87·8% (83·7 to 90%) 
indicated that the majority of power is within the delta band, with 95% of power 
(spectral edge frequency) below a median of 7·56 Hz (IQR: 6·17 to 9·76 Hz).  Total 
power was highest at lower frequencies. The highest values were in the 0·5-4 Hz 
band, with median (IQR) spectral power measuring 70·5 (42·8 to 171·4) µV
2
. The 
lowest values for total power and relative power were in the 13-30 Hz band, 
measuring 2·5 (1·2 to 4·6) µV
2
 and 2·5% (1·8 to 3·6%) respectively. Figure 4.3 
illustrates a power-law spectrum, with decreasing power for increasing frequency, 
within the 0·5-30 Hz range for all infants’ EEG. The median (IQR) fractal dimension 
of 1·1 (1·1 to 1·1) equates to a power law slope α of 2·8 (2·7 to 2·8). Median power-
law slope, in turn, equates to a log-log spectral slope of -28 dB/decade, as highlighted 
in Figure 4.3.  
 
For the median values over all EEGs, lower and upper margins of the rEEG spanned 
from 14·5 to 63·3 µV with a median rEEG of 24·4 µV. 
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Table 4.2 Quantitative features of the EEG 
 
 
 
 
 
 
 
 
 101 
 
Figure 4.3 Power spectral density (PSD) estimates for both channels of the EEG 
 
 
 
 
 
 
 102 
4.4 Discussion 
This study describes, for the first time, detailed features of continuous neonatal EEG 
during newborn transition. Continuous mixed frequency EEG was obtained within the 
first few minutes of birth, and quantitative EEG reference values for healthy newborn 
infants during the immediate newborn period have been produced.   
 
Over the past 30 years neonatal EEG monitoring has become an essential tool for the 
assessment of neurological function in infants with perinatal asphyxia (231-234), 
seizures (200, 235, 236, 247), and more recently in the care of premature infants 
(248). Approximately 20 per 1000 deliveries will require significant stabilisation 
measures, with biochemical and clinical evidence of perinatal asphyxia (249). Of 
these only 1.5 per 1000 deliveries will go on to develop signs of evolving 
encephalopathy consistent with HIE (250). Given the potential benefit of early 
treatment with therapeutic hypothermia, the need to identify infants with HIE in the 
immediate newborn period is becoming increasingly important (251-253). However, 
to date our understanding of early newborn brain activity is based on studies in unwell 
infants, or in well infants after 3-6 hours of age (131, 221, 241, 245, 253).  Many 
infants with HIE are born at regional hospitals which do not offer TH and require 
transfer to a tertiary facility, resulting in a delay in the initiation of TH. To address 
this, many infants are cooled passively during transport from the regional hospitals 
(254). It is therefore important that the correct infants are transferred and passively 
cooled. A simple method of assessing brain health at regional hospitals would also 
help to accurately identify those infants that require transfer to a tertiary centre.    
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Pichler et al. performed aEEG in infants > 34 weeks gestation following elective 
caesarean section (105). Recordings were feasible after three minutes in some infants. 
However, continuous reliable data was difficult to obtain in their initial study (105). 
The upper and lower limits of the aEEG were correlated with simultaneous values 
obtained from near infrared spectroscopy recordings (98). Low EEG values during 
immediate transition after birth concurrently showed low cerebral oxygenation values, 
but with associated increased cerebral oxygen extraction (194). These studies, along 
with the current study, show that EEG   monitoring is feasible immediately after 
delivery. However, second by second EEG information was not reported in the 
previous studies, and importantly, the EEG was not analysed using objective 
quantitative measures. As mentioned previously, heavy signal processing used in the 
aEEG algorithm eliminates much of the detail (e.g. frequency band content) available 
in the EEG and many clinically important features are lost.  
 
Continuous neonatal EEG can be assessed both qualitatively and quantitatively. 
Qualitative EEG analysis is mainly used for clinical purposes. It is based on visual 
interpretation of the EEG signal and describes such background features as amplitude, 
frequency, and continuity, symmetry and synchrony of the EEG. Reference values 
within the first 12 hours of age are available for healthy term newborns (241). 
Quantitative EEG analysis is a method predominantly used in research and includes 
time and frequency domain analysis. Quantitative analysis allows for standardized 
reporting of EEG values, which is imperative when establishing new reference ranges. 
Crucial to this standardization process is a precisely defined set of quantitative 
features, including implementation and parameter details. These details are available 
in reference (206). Quantitative analysis can also be used to objectively grade baseline 
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EEG activity in sick newborn infants and can provide decision support with EEG 
analysis when clinical neurophysiologists are not available (255).  
 
Continuous mixed frequency EEG can be obtained in infants during the immediate 
newborn period. Activity with an amplitude of 25-50μV was seen in all healthy term 
infants immediately after birth. Early EEG suppression has been reported in infants 
following hypoxic-ischaemic injury and is associated with long-term outcomes (143, 
197). Quantitative analysis has value in differentiating between HIE grades (256). 
Quantitative values for amplitude, power, and range EEG during newborn transition 
are now reported.  As this is the first study to provide such values it is difficult to 
make comparisons. Total and relative spectral power change over time in infants as 
they mature and we found that the majority of power was in the delta EEG band 
during newborn transition (257). 
 
A prior study by our research group reported 
quantitative features for healthy term infants during active and quiet sleep in the first 
day of life (241). Mean relative delta power was 73% (5%) and 79·5 (4%) during 
active and quiet sleep respectively, displaying again that the majority of power was in 
the delta band.  
 
This study has a number of limitations. We did not include data on the exact timing of 
cord clamping in each baby. Infants were monitored for relatively short periods of 
time. Longer EEG monitoring and serial studies within the early postnatal period 
might be useful. However, such studies are challenging in the immediate newborn 
period and we were reluctant to interfere with newborn bonding and the establishment 
of newborn feeding.  The number of infants recruited was small. However, 
quantitative analysis produced values, which had narrow ranges in our homogenous 
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study group.  Further studies are required to assess whether brain activity differs by 
mode of delivery, delivery room interventions and stabilisation methods utilized. EEG 
monitoring in the delivery room may have a key role to play in identifying those 
infants with mild perinatal asphyxia who may benefit from immediate intervention 
but again, significantly larger studies are required.  Whilst EEG may also have the 
potential to direct therapy in the delivery room, in particular cessation of resuscitative 
efforts, there is an absolute lack of data in this regard and we would not advocate such 
an approach.  
 
To our knowledge, this study is the first to describe normative quantitative EEG data 
in healthy full term infants during transition. These findings are relevant and clinically 
important. Therapeutic hypothermia must be administered to newborn babies with 
HIE within the first few hours of birth and delivery room EEG may help identify 
those babies that are most suitable for treatment, especially infants with clinically 
suspected mild encephalopathy. However, further trials are now warranted to assess 
the utility of EEG recordings during newborn transition.  
 
In conclusion, EEG acquisition in the delivery room is feasible and brain activity in 
the first minutes of life can be recorded. Normative quantitative values for EEG 
during newborn transition have been produced for the first time. Future trials will 
need to assess EEG in the first minutes of life following in infants at risk for 
encephalopathy to assess its clinical utility. 
 106 
Chapter 5  
Neuromonitoring in the immediate newborn period in 
a randomized controlled trial of cord clamping in 
preterm infants less than 32 weeks: Clamping the 
Umbilical cord in Premature Deliveries (CUPiD) 
5.1 Introduction 
Preterm brain injury is a major worldwide public health problem. Approximately one 
in 70 babies (1.4%) are born before 32 week gestation; however as a group they 
account for over half  (51%) of infant deaths (258). Of very preterm infants who 
survive, 5- 10% develop cerebral palsy, and those without severe disability have a 
twofold-increased risk for developmental, cognitive, and behavioural difficulties (259, 
260).  
 
Following delivery, the umbilical cord may be clamped immediately, or as an 
alternative procedure placental transfusion may occur, either by delaying cord 
clamping (DCC) for a period of time, or by milking the umbilical cord (UCM) (261). 
Allowing for placental transfusion of blood following preterm delivery, either by 
DCC or UCM, has been shown to decrease the incidence of intraventricular 
haemorrhage (IVH) by 50%, but has not affected neurodevelopmental or mortality 
outcomes (262). Although not fully understood, animal models suggest that a reduced 
incidence of IVH may be explained by a smoother cardiovascular transition when 
ventilation precedes cord clamping (263, 264). 
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Current recommendations on timing of cord clamping are not explicit (13).  American 
and European guidelines have recommended a delay before clamping the umbilical 
cord to facilitate placental fetal transfusion in preterm infants who are not 
compromised at birth (265)(266). For compromised infants, ICC is still 
recommended, although it is postulated that compromised preterm infants may benefit 
the most from placental-fetal transfusion. The RCOG have highlighted the need for 
research centres to actively explore the feasibility of bedside resuscitation to allow for 
delayed cord clamping in compromised infants, and to consider UCM, although 
neither approach should be considered routine until more evidence is available (267). 
  
Umbilical cord clamping is an important intervention in preterm infant health and 
gaps in our knowledge exist. It is surprising that a reduction in IVH following DCC or 
UCM has not translated into superior developmental outcomes compared to ICC 
(262). This study aims to investigate how different cord clamping strategies affect 
preterm infant short-term neurological wellbeing, and improve our understanding of 
how different cord clamping strategies affects cerebral activity and oxygenation. By 
design, EEG and NIRS monitoring in the immediate newborn period have been 
incorporated as primary outcome measures. The feasibility of monitoring cerebral 
activity (EEG) and oxygenation in preterm infants in the immediate newborn period 
following an interventional DR study will be assessed. Also, the benefits and 
limitations of using infant neuromonitoring as a primary outcome in a preterm 
randomized controlled trial will be determined.   
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5.2 Methods 
5.2.1 Study Design and Population 
This prospective randomized controlled trial was conducted in Cork University 
Maternity Hospital (CUMH), Ireland over a nine-month period from December 2015 
– September 2016. Infants born at less than 32 weeks gestational age (from 23+0 
weeks’ up to and including 31+6 weeks’ gestational age) based on the earliest 
ultrasound or last menstrual period were eligible for inclusion. Exclusion criteria 
included inability to obtain informed consent from parent, major congenital anomaly, 
bleeding from placenta praevia, clinical suspicion of placental abruption or accreta, 
monochorionic multiples with known or suspected twin to twin transfusion syndrome, 
with significant growth discordance (>10%), Rh sensitization, hydrops, and cord 
prolapse.   
There were three arms - ICC, UCM and DCC with bedside respiratory support.  A 
designated member of the neonatology research team started the Apgar timer at the 
time of delivery, and recorded the time of cord clamping. ICC was defined as 
clamping the infants’ umbilicus within 20 seconds of delivery, and routine neonatal 
care commenced immediately. For UCM the obstetrician held the infant at or below 
the level of the placenta, and his/her assistant stripped the cord 3 times in the direction 
of the infant. Each stripping aimed to cover a maximum 20 cm of cord, at a speed of 
20cm/2seconds, and 2 seconds were allowed in between each milking to allow the 
cord to refill.  For DCC, infants were placed on a mobile resuscitation trolley 
(Lifestart, Inspiration Healthcare, UK) with the cord intact, and at or below the level 
of the placenta. Routine neonatal care was provided and the cord clamped at 60 
seconds following delivery. All members of the resuscitation team were Neonatal 
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Resuscitation Program (NRP) trained and followed current NRP guidelines in the 
management of preterm infants in the delivery room. All infants were wrapped in 
sterile towels at the time of delivery until they were transferred to the Panda 
Resuscitator (GE Healthcare, Laurel, MD, USA). 
 
5.2.2 Randomisation 
Randomisation was performed using a computer based randomisation program and 
allocation concealment was achieved by using opaque, sequentially numbered, sealed 
envelopes. Randomisation was stratified by age (23+0 to 27+6 and 28+0 to 31+6 
weeks) to ensure equal numbers of neonates born at <28 weeks’ gestation in each arm 
with a 1:1:1 allocation ratio between the three groups using random block sizes of 3 
or 6. Multiples received the same group allocation. Immediately before delivery, the 
investigator opened the envelope and made the obstetrician aware of the group 
allocation of the infant. 
5.2.3 Ethical approval and consenting procedure 
Antenatal written informed consent was obtained prior to delivery. The Cork 
Teaching Hospitals’ Research Ethics Committee approved this study. This trial was 
registered on the ISRCTN registry with trial number ISRCTN92719670. 
 
5.2.4 Neuromonitoring 
All infants had cerebral near infrared spectroscopy and electroencephalography 
(EEG) monitoring commenced as soon as possible following delivery, which was 
dependent on infant stability, and monitoring continued until 72 hours of age. A NIRS 
neonatal probe, OxyAlertTM NIRSensor (Covidien IIc, Mansfield, MA, USA) was 
 110 
applied in a fronto temporal location. EEG was recorded with the NicoletOne 
(CareFusion Co., San Diego, USA) or Moberg (Moberg Research Inc., PA, USA) 
EEG systems. Depending on infant size 4- 11 electrodes were positioned according to 
the international 10–20 system of electrode configuration over the frontal, central, 
temporal, and occipital regions, a reference electrode at Fz, and a ground electrode 
behind the left ear. The method for electrode placement in preterm infants in our unit 
has previously been described (205). A consultant radiologist (unaware of group 
assignment) performed a cranial ultrasound within 48 hours of delivery and then 
according to our neonatal unit’s practice.   
 
5.2.5 Outcome Measures 
Primary neonatal outcome was standard quantitative measures of preterm newborn 
EEG and NIRS median values collected over 1 hour time frames at both 6 and 12 
hours of life. The authors analyzing NIRS and EEG were blinded to randomization 
allocations. Primary outcome for maternal outcome was maternal hemoglobin at 24-
36 hours post-partum. 
All EEGs were assessed visually for quality and any epoch with poor signal was not 
used further. In addition, each EEG was visually assessed for overall discontinuity, 
amplitude and also symmetry and synchrony (where possible i.e. for recordings that 
utilized multiple channels of EEG). One channel of EEG, common to all recordings 
(C4-C3) was then assessed using a set of quantitative EEG measures to represent the 
complex waveforms of the preterm EEG (206). Before generating the feature set, an 
automated method removed segments of EEG corrupted by artefact (206). The feature 
set included spectral power, relative spectral power, and spectral flatness measures. 
These spectral measures were calculated in 4 frequency bands: 0.5–3, 3–8, 8–15, 15–
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30 Hz (206). Features of the range-EEG and burst duration were also included in the 
feature set. The range-EEG used a 1–20 Hz bandpass filter and median, lower- and 
upper-margins were calculated (206). Features of the temporal organization of bursts 
included burst percentage and the 95
th
 percentile of the duration of inter-burst 
intervals (IBI). Bursts and IBI were identified on the EEG using an automated method 
(268). IBI are the periods of relative quiescence (low voltage activity) that occur in 
between consecutive bursts of activity. Their duration has been shown to reflect brain 
maturation, being associated with the development of cortical folding (269). IBI 
duration decreases with GA and the EEG burst ratio is a standard quantitative 
measure used to characterize maturation (166). All quantitative measures were 
calculated  using the software package NEURAL (v0.3.3), a neonatal EEG feature set 
in Matlab (206). NEURAL was developed to standardize quantitative analysis of 
newborn EEG by including full implementation details with freely available open 
source code (206). Cerebral oxygenation values were averaged over a one-hour period 
at 6 and 12 hrs of age.  
 
Secondary neonatal outcome measures included mean blood pressure over 48 hours, 
temperature on admission, haemoglobin at 12 hours, IVH and BPD.  Severe IVH was 
defined as Grade III/IV according to Papile classification (270). BPD was defined as 
oxygen requirement at 36 weeks corrected gestational age. 
Echocardiographic measurements were performed on all infants at 12 hours +/-3 
hours of age. Measurements were taken to assess systemic blood flow, by superior 
vena cava (SVC) flow (ml/kg/min), right ventricular output (ml/kg/min), and left 
ventricular output (LVO)(ml/kg/min) (208).  
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5.2.6 Sample Size 
As this was a pilot study and preterm infants have not been previously studied in this 
context, a formal sample size calculation was not performed. During the 9-month 
study period, all infants who were assessed, met the eligibility criteria and consented 
were enrolled in the study. 
 
5.2.7 Data Collection and Statistical analyses  
All information was collected by research fellows or a research nurse and stored in a 
password-protected database. Categorical data was described numerically using 
frequency and percentage (%) and continuous data using median (interquartile range, 
IQR). Differences in categorical variables between the three groups were investigated 
using Fisher’s exact test. Differences in continuous variables between the three 
groups were investigated using the Kruskal-Wallis test and if statistically significant 
differences were found between the three groups, pairwise comparisons were 
performed using the Mann-Whitney U test, with Bonferroni correction. All tests were 
two-sided and a p-value<0.05 was considered to be statistically significant.  
The primary analysis was intention-to-treat (ITT).  A linear mixed-model was used to 
test for differences among the 3 groups (DCC, UCM, and ICC) in each quantitative 
measure of the EEG and NIRS. Fixed effects included gestational age, time after birth 
(either 6 or 12 hours), group membership, and the interaction between group and 
time. Gestational age was included as many quantitative measures of the EEG are 
dependent on maturation (271). A backwards selection procedure was used to test to 
the significance of each fixed effect in the linear model; for more details on this 
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process, see example (272). All statistical analysis was performed using IBM SPSS 
Statistics version 22. 
5.3 Results 
5.3.1 Study Participants 
There were 77 patients assessed for eligibility over the 9-month study period. A total 
of 45 participants were enrolled. A total of 12 infants (12/45, 27%) were randomized 
to ICC, 19 to UCM (19/45, 42%), and 14 to DCC with bedside resuscitation (14/45, 
31%). Two infants randomized to DCC received ICC, both being delivered prior to 
the resuscitation trolley being prepared in time. There was no statistical difference in 
median gestation or birthweight between groups (Table 5.1). All infants received 
antenatal steroids and all but one (in ICC group) received antenatal magnesium. One 
infant was excluded at delivery as the infant was noted to be dysmorphic and 
subsequently died in the DR (see Figure 5.1).  
Figure 1 Flow Diagram  
 
 
 
 
 
 
 
 
 
 
 
Assessed for eligibility 
 (n=77) 
Randomized (n=45) 
Excluded (n=32) 
 To participate (n=8) 
 Insufficient time to consent 
(n=17) 
 Placental Abruption (n=2) 
 Suspected twin to twin 
transfusion (n=4) 
 Known Congenital Anomaly 
(n=1) 
Allocated to ICC 
(n=12) 
Received allocated 
intervention n=12 
Allocated to DCC 
(n=14) 
Received allocated 
intervention n=12 
Allocated to UCM 
(n=19) 
Received allocated 
intervention n=19 
Excluded in DR as RIP 
n=1 
Analyzed (n=12) 
 
Excluded from 
analysis (n=0) 
Analyzed (n=14) 
 
Excluded from 
analysis (n=0) 
Analyzed (n=18) 
Excluded from 
analysis as monitoring 
not possible n=1 
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Table 5.1 Infant characteristics  
median (IQR)1 median (IQR)1 median (IQR)1 p-value2
Gestation (weeks) 28.5 (25.7 to 30.5) 28.0 (26.4 to 29.6) 28.4 (25.7 to 29.6) 0.889
Birthweight (g) 1080 (755 to 1613) 925 (630 to 1490) 930 (700 to 1545) 0.798
Multiples: n(%) 2 (16.7) 4 (28.6) 13 (72.2) 0.0053
Antenatal steroids: n(%) 12 (100) 14 (100) 18 (100) 13
Magnesium: n(%) 11 (91.7) 14 (100) 18 (100) 0.2733
1unless otherw ise stated; 2from Kruskal-Wallis test unless otherw se stated; 3from Fisher's exact test
ICC
(n=12)
DCC
(n=14)
UCM
(n=18)
 
5.3.2 Primary Outcome Measures 
A summary of primary outcome measures can be seen in Table 5.2. Tables 5.3 and 
5.4 include a complete list of EEG features analyzed at 6 hour and 12-hour time 
points. 
 
5.3.2.1 EEG Outcome 
Application of EEG and acquisition of data was performed as early as possible. Seven 
infants had EEG monitoring commencing in the DR. Median (IQR) age at EEG 
application was 3.05 (1.85 to 5.38) hrs. For primary outcome measures, data on 42/44 
(95%) was available at 6 hours and 44/44 (100%) at 12 hours. All but one EEG was 
deemed appropriate for age in terms of amplitude and continuity. One infant had a 
very immature EEG pattern for age and was not used in quantitative analysis. As 
Tables 5.3 and 5.4 show, no significant differences were found between the three 
groups at either time point in the unadjusted and adjusted analysis. Also, in the linear 
mixed models, the interaction of group by time (or group) was not significant for any 
of the 17 EEG features. GA was significant for some (7/17) features, as was time 
(8/17), but not group or group-by-time interaction (0/17).  Figure 5.2a-c highlights the 
dependency of 3 EEG features on gestational age but not on intervention group.  
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Figure 5.2 EEG features (a. – c.) highlighting the dependency on gestational age. 
Mixed-effect models for the 3 features included gestational age as a fixed effect 
(lines in a. – c.). Time (either the 6 or 12 hour time point) was significant (P value 
<0.05) in the rEEG-median feature plotted in c. but not for the features in a. and 
b. The fixed effects of intervention group 
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5.3.2.2 NIRS Outcome 
NIRS data was available for all 44 infants at both time points. There was no 
significant difference in rcSO2 values among the 3 groups at 6 or 12 hour time points 
(Table 5.2). Also, in the linear mixed model, the interaction of group by time (or 
group) was not significant.  
 
5.3.2.3 Maternal haemoglobin 
There were no significant differences between maternal haemoglobin values between 
groups (p=0.36). Median (IQR) values were highest in the ICM group (10.8, 10.3-
11.6g/dL), and lowest in the UCC group (10.15, 9.5-11.9). 
 
Table 5.2 Primary Outcome Measures  
 UCM DCC ICC p-value p-value 
     (adjusted) 
burst ratio [6-hours] (%) 83 (69 to 89) 68 (59 to 86) 76 (67 to 91) 0.27 0.16 
burst ratio [12-hours] (%) 83 (72 to 93) 81 (66 to 90) 82 (73 to 89) 0.95 0.96 
rEEG: median [6-hours] (μV) 30 (21 to 33) 22 (18 to 30) 28 (22 to 33) 0.60 0.56 
rEEG: median [12-hours] (μV) 31 (27 to 37) 30 (23 to 40) 28 (24 to 34) 0.61 0.57 
rcSO2 [6 hours] (%) 83 (76 to 88) 85 (74 to 87) 87 (72 to 89) 0.94 0.97 
rcSO2 [12 hours] (%) 
Maternal Hb (g/dL)
 
80 (76 to 87) 
10.2 (9.5 to 
11.9) 
81 (75 to 89) 
10.3 (9.4 to 
11.4) 
79 (74 to 82) 
10.8 (10.3 to 
11.6) 
0.91 
0.36 
0.88 
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Table 5.3 Quantitative EEG analysis at 6 hours 
 
 
qEEG feature UCM DCC ICC P-value P-value 
 mean (SD) mean (SD) mean (SD)  (adjusted) 
rEEG: median (μV) 28.8 (7.4) 25.9 (10.5) 28.9 (9.7) 0.60 0.56 
rEEG: lower margin (μV) 11.1 (3.8) 9.5 (4.0) 10.8 (4.6) 0.55 0.48 
rEEG: upper margin (μV) 134 (42) 140 (50) 118 (36) 0.45 0.43 
burst ratio (%) 79 (13) 70 (19) 79 (15) 0.27 0.16 
maximum IBI (seconds) 9.7 (4.2) 13.2 (7.6) 9.7 (5.3) 0.42 0.35 
SP [0.5–3 Hz] (μV2) 440 (270) 453 (305) 372 (173) 0.94 0.94 
SP [3–8 Hz] (μV2) 29 (14) 30 (15) 25 (15) 0.63 0.64 
SP [8–15 Hz] (μV2) 6.5 (2.6) 6.9 (3.2) 6.0 (2.4) 0.85 0.81 
SP [15-30 Hz] (μV2) 2.2 (1.2) 2.0 (1.0) 2.2 (1.3) 0.89 0.90 
relative SP [0.5–3 Hz] (%) 90.8 (4.6) 91.4 (2.5) 91.6 (2.9) 0.81 0.81 
relative SP [3–8 Hz] (%) 6.6 (2.6) 6.3 (1.7) 6.0 (2.5) 0.75 0.75 
relative SP [8–15 Hz] (%) 1.66 (0.90) 1.65 (0.82) 1.68 (0.67) 0.97 0.97 
relative SP [15–30 Hz] (%) 0.69 (0.74) 0.50 (0.25) 0.63 (0.32) 0.70 0.70 
SF [0.5–3 Hz] 0.292 (0.087) 0.295 (0.038) 0.290 (0.042) 0.98 0.99 
SF [3–8 Hz] 0.749 (0.064) 0.749 (0.060) 0.765 (0.055) 0.75 0.74 
SF [8–15 Hz] 0.830 (0.031) 0.814 (0.028) 0.834 (0.036) 0.30 0.29 
SF [15–30 Hz] 0.657 (0.072) 0.631 (0.036) 0.669 (0.044) 0.28 0.28 
qEEG: quantitative EEG; SP: spectral power; SF: spectral flatness; UCM: umbilical 
cord milking; DCC: delayed cord clamping; ICC: immediate cord clamping 
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Table 5.4 Quantitative EEG analysis at 12 hours 
 
qEEG feature UCM DCC ICC P-value P-value 
 mean (SD) mean (SD) mean (SD)  (adjusted) 
rEEG: median (μV) 31.5 (9.4) 31.7 (10.7) 28.3 (7.2) 0.61 0.57 
rEEG: lower margin (μV) 11.0 (3.0) 11.0 (4.0) 10.1 (3.6) 0.77 0.67 
rEEG: upper margin (μV) 150 (58) 156 (54) 127 (40) 0.38 0.35 
burst ratio (%) 80 (16) 78 (14) 80 (14) 0.95 0.96 
maximum IBI (seconds) 10.0 (6.8) 10.6 (6.4) 9.1 (3.3) 0.92 0.93 
SP [0.5–3 Hz] (μV2) 610 (384) 615 (503) 446 (227) 0.79 0.79 
SP [3–8 Hz] (μV2) 36 (20) 35 (24) 27 (19) 0.64 0.65 
SP [8–15 Hz] (μV2) 7.1 (3.1) 8.4 (4.8) 6.1 (2.3) 0.48 0.44 
SP [15-30 Hz] (μV2) 2.3 (1.0) 3.3 (3.3) 2.1 (0.7) 0.56 0.55 
relative SP [0.5–3 Hz] (%) 92.2 (2.4) 92.1 (2.4) 92.3 (3.5) 0.99 0.98 
relative SP [3–8 Hz] (%) 5.7 (1.5) 5.5 (1.4) 5.5 (2.8) 0.69 0.69 
relative SP [8–15 Hz] (%) 1.37 (0.67) 1.59 (0.76) 1.51 (0.74) 0.63 0.53 
relative SP [15–30 Hz] (%) 0.55 (0.41) 0.61 (0.52) 0.57 (0.37) 0.87 0.86 
SF [0.5–3 Hz] 0.284 (0.062) 0.307 (0.047) 0.275 (0.040) 0.28 0.28 
SF [3–8 Hz] 0.745 (0.068) 0.762 (0.061) 0.767 (0.052) 0.59 0.54 
SF [8–15 Hz] 0.836 (0.024) 0.810 (0.048) 0.830 (0.031) 0.11 0.10 
SF [15–30 Hz] 0.631 (0.077) 0.627 (0.038) 0.640 (0.047) 0.86 0.86 
qEEG: quantitative EEG; SP: spectral power; SF: spectral flatness; UCM: umbilical 
cord milking; DCC: delayed cord clamping; ICC: immediate cord clamping 
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5.3.3 Secondary Outcome Measures 
Whilst two infants in the ICC group had a severe IVH compared to one infant in 
the UCM group and no infant in the DCC group, the difference between groups 
was not statistically significant (P value 0.35). There was no difference in 
admission temperature, mean blood pressure on admission and at 6, 12, 18 and 24 
hours, or BPD (Table 5.5).  
 
Markers for systemic blood flow based on echocardiographic measurements did not 
differ significantly between groups (Table 5.5). Median (IQR) values for SVC flow 
were lowest in the ICC group 50 (47 to 77) and highest in the DCC with bedside 
resuscitation groups 106 (82.4 to 166). 
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Table 5.5 Secondary Outcome Measures  
n median (IQR)1 n median (IQR)1 n median (IQR)1 p-value2
Temperature (on admission) 12 36.3 (36.2 to 36.8) 14 36.4 (36 to 36.6) 18 36.6 (36.3 to 36.8) 0.24
Hb (g/dl) 12 hrs 12 16.6 (15.8 to 17.9) 14 17.1 (16.0 to 18.8) 18 15.7 (14.2 to 17.7) 0.46
MBP (mmHg) 6 hrs 9 30 (25.5 to 38) 14 31 (27.5 to 33) 15 34 (26 to 37) 0.41
MBP (mmHg) 12 hrs 12 34.5 (31 to 40) 13 32 (27 to 36) 16 33.5 (29 to 36.8) 0.50
MBP (mmHg) 18 hrs 10 36.5 (32 to 42) 14 33 (29.8 to 37) 16 33.5 (30.3 to 39) 0.33
MBP (mmHg) 24 hrs 12 38.5 (36.3 to 40.8) 14 36 (33.5 to 37.3) 18 38 (33 to 40.3) 0.22
LVO (mls/kg/min) 7 95 (89 to 129) 7 120 (85 to 156) 9 142 (67 to 236) 0.58
RVO (mls/kg/min) 7 149 (89 to 174) 7 137 (136 to 183) 9 232 (92.5 to 442) 0.37
SVC (mls/kg/min) 7 50 (47 to 77) 7 106 (82.4 to 166) 8 69 (30 to 117.8) 0.11
IVH severe: n (%) 12 2 (17) 14 0 (0) 18 1 (6) 0.353
BPD: n (%) 12 5 (42) 14 8 (57) 18 9 (50) 0.703
1unless otherw ise stated; 2from Kruskal-Wallis test unless otherw se stated; 3from Fisher's exact test
Hb- haemoglobin; MBP- mean blood pressure; LVO- left ventricular output; RVO- right ventricular output; SVC- superior vena cava flow ; IVH severe- intraventricular haemorrhage Grade III or IV; 
BPD- bronchopulmonary dysplasia
UCMICC DCC
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5.4 Discussion 
This prospective RCT assessed short-term neurological health in preterm infants < 32 
weeks gestation following 3 different cord clamping strategies. Monitoring 
commenced as early as possible, and EEG application was prioritized over NIRS. 
EEG  monitoring was achieved in 95% of infants by 6 hours, and 100% by 12 hours, 
which were the pre-specified primary outcome measurement times. NIRS data was 
available for 100% of infants at 6 and12 hours. Therefore, performing EEG and NIRs 
in the immediate newborn period is feasible in an interventional preterm infant study. 
 
There were no significant differences in cerebral oxygenation values or quantitative 
EEG features between groups at either 6 or 12 hours. Whilst two infants in the ICC 
group had a severe IVH compared to one infant in the UCM group and no infant in 
the DCC group, the difference between groups was not statistically significant. 
 
Until recently immediate cord clamping had been considered gold standard for 
preterm deliveries, as it allowed for immediate movement of the newborn infant to the 
resuscitation area for stabilization (273).  Renewed interest in the area has been led by 
studies proposing benefits for newborn infants by utilizing alternative cord clamping 
strategies, namely umbilical cord milking, and delayed cord clamping, which with the 
advent of mobile resuscitation trolleys allows for immediate support if required. 
Improved neonatal outcomes, without maternal side effects, are based on large 
retrospective review studies.  A recent Cochrane review (which included 15 studies, 
n= 738) by Rabe et al highlighted a 50% decrease in IVH of all grades when DCC is 
employed compared with ICC (262, 274-281). However there was no reduction in the 
incidence of severe IVH grades, which are more likely to result in long-term 
 122 
neurodevelopmental problems. Also, the current evidence base is less robust for long-
term neurodevelopmental outcomes. The review was unable to comment on whether 
DCC affected the incidence of grade 3 or 4 IVH, and developmental scores at 7 
months were equivocal (262). In a meta-analysis of 3 trials (n=99) no difference in 
neurodevelopment outcomes at 18- 24 months was observed between ICC and DCC 
groups (282). Meta-analyses on UCM have found similar reductions in IVH when 
compared to ICC, without long-term neurodevelopmental benefits (1, 283).  Two 
large randomized controlled trials have recently been published. The APTS study 
compared ICC versus DCC and found no difference in a composite outcome which 
included death and a number of neonatal morbidities (284). Mortality alone was 
higher in the immediate group (9%) compared to the delayed group (6.4%) but this 
difference was no longer significant when correction for multiple comparisons took 
place. Duley and colleagues compared cord clamping at less than 20 seconds to 
delayed cord clamping with bedside resuscitation (285). They found a difference in 
death before discharge (ICC: 11%, DCC: 5%), but this was based on a small number 
of events with a wide confidence interval. Also, there are no clear differences between 
the groups in IVH or any other serious morbidity that would potentially explain a 
difference in mortality. The authors concluded that further trials assessing DCC with 
bedside resuscitation are urgently needed (285). 
 
Recent evidence from animal studies suggests that benefits from DCC result from a 
more stable haemodynamic transition (263, 264). Clamping the umbilical cord 
increases systemic peripheral resistance as the neonatal circulation abruptly switches 
from a parallel to a series circuit. Ideally pulmonary ventilation should precede cord 
clamping to enable pulmonary venous return to immediately replace umbilical venous 
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return and the large adverse changes in cardiac function that normally accompanies 
umbilical cord clamping can be avoided (263, 286). Increased fluctuations in cardiac 
output and immature cerebral vascular autoregulation might help explain the 
increased risk of IVH following ICC in premature infants (287). In a recent study in 
preterm lambs a smoother cardiovascular transition was observed when ventilation 
preceded cord clamping (263). Ventilation with delayed cord clamping was associated 
with less variability in carotid artery pressure, and carotid artery blood flow in 
newborn lambs. However, these findings do not explain why UCM should result in 
similar reduction in IVH rates. Our understanding of the physiological outcomes 
resulting from different cord clamping strategies remains limited, and our study aimed 
to investigate short-term neurological outcomes in such instances.   
 
Our study displayed different patterns, although not significant, in preterm infant 
brain oxygenation following alternative cord clamping strategies. There were no 
significant differences in cortical activity when measured by a comprehensive set of 
quantitative EEG measures. Fewer severe IVHs occurred in the placental transfusion 
groups, but we acknowledge that there were low numbers and this finding was not 
statistically significant. Cerebral activity and maturation did not differ between the 
groups, which may reflect low study numbers, or alternatively, different cord 
clamping strategies may not affect cerebral activity at the time points assessed in our 
study.  
 
There were no differences for maternal complications, neonatal stabilisation 
interventions, neonatal temperature, blood glucose, or phototherapy days. This is 
important as current recommendations now advise neonatal units to take part in 
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studies, which assess alternative cord clamping strategies (267). This study highlights, 
as an aside, the feasibility of safely conducting a single centre RCT with UCM and 
DCC with bedside resuscitation as experimental arms.  
 
EEG monitoring was commenced as early as possible post delivery. However, only 
16% (7/44) had EEG applied in the DR. All infants were < 32 weeks and were 
commenced on positive end expiratory pressure (PEEP) following delivery. The small 
preterm cranial sizes, and the position of the neonatologist’s hands around the infants’ 
head in order to apply effective PEEP, meant that it was virtually impossible to apply 
EEG electrodes without interference. Therefore, EEG monitoring was only 
commenced in larger, stable infants in the DR to ensure that newborn stabilisation 
was not affected. It was subsequently applied when the newborns were stabilised in 
the neonatal unit.  
 
There are a number of limitations to this study. Firstly, the study was not powered to 
an appropriate level to display superiority between cord clamping strategies based on 
our primary outcome measures. We recruited small study numbers as it was designed 
as a single center study and studies have not been previously conducted which utilized 
EEG and NIRS in similar circumstances on which to calculate sample sizes. Of note, 
because of limitations in spatial EEG recording, we did not examine specific 
maturational features of the EEG that are known to correlate with poor outcomes, 
such as mechanical delta brushes, and positive rolandic sharp waves. Our analysis of 
the EEG was based entirely on the quantitative features of one central cerebral 
channel of EEG. The number of infants in each group with a comprehensive set of 
EEG recording electrodes was too small to analysis as a subset set for this study.  
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Secondly, our infants were not evenly randomized among interventional groups. This 
was as a result of multiples being randomized to the same intervention and a higher 
number of multiples receiving UCM. Finally, some research groups now believe that 
there is ample evidence for the benefits of UCM and DCC such that ICC should no 
longer be included in such studies. The recent results of the APTS and CORD trial 
have provided further information, which may be informative to future trials in this 
area.  
 
In conclusion, preterm infant neuromonitoring is feasible as part of a RCT with a 
short term surrogate of brain health as a primary outcome determined in the first 12 
hours of life. Acquiring data on brain activity and cerebral oxygenation at predefined 
times was feasible. There were no differences in quantitative EEG measures and 
cerebral oxygenation values between cord management strategies at 6 and 12 hours. 
Although our study numbers were small, rates for severe IVH differed among 
different cord clamping strategies. These findings did not reach statistical 
significance, but do add to our understanding of the short-term neurological outcomes 
following different cord clamping strategies. 
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Chapter 6  
Conclusion and future directions 
 
6.1 Conclusions 
Neonatal mortality has decreased significantly in recent decades (271). As more 
infants survive following preterm delivery and birth asyphxia, achieving the best 
possible neurological outcomes for survivors is paramount. Whilst EEG has an 
essential role within the NICU in newborn neurological monitoring following birth 
asyphxia, and more recently in monitoring preterm infants, it is not routinely initiated 
in the immediate newborn period, and at present has no role during newborn 
stabilisation.  
 
The studies performed and presented as part of this thesis set out to determine if 
firstly it was feasible to perform newborn EEG in the DR, and secondly to assess 
what information it provides about newborn brain activity in the immediate postnatal 
period. The potential role for preterm infant neuromonitoring in the immediate 
newborn period was also explored as part of an interventional preterm infant RCT.  
 
Monitoring brain activity in term infants in the DR is feasible and can be obtained in 
the first minutes of life by an experienced user. Continuous mixed frequency EEG can 
be seen in all infants, and quantitative features have now been described for the first 
time. The quantitative features reported represent infants during the immediate 
newborn period following the establishment of functional residual capacity, and 
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stabilisation of tidal volumes and end tidal CO2, in term infants following elective 
caesarean section.  
 
Preterm infant neuromonitoring is also feasible in the immediate newborn period. The 
acquisition of EEG is not as straightforward as in healthy term infants with current 
application techniques. However, it is possible to obtain information on brain activity 
and cerebral oxygenation during the first hours of life. In the study reported, the 
majority of infants had information available early, within hours of birth.  
 
6.2 Future directions 
6.2.1 EEG as a biomarker for brain health in the immediate newborn period 
Brain activity can be monitored in the immediate newborn period, and normative 
values have now been produced. This information is hugely important, beneficial and 
may help guide resuscitation teams and to determine the need for immediate passive 
cooling. Thoresen et al coined the phrase ‘time is brain’ in relation to the timing of 
cooling for neuroprotection (151). We strongly believe that EEG in the DR could help 
identify those infants who would benefit most from early neuroprotective strategies.   
 
However, we still have a way to go before EEG monitoring is routine in the DR. 
Signal interpretation is difficult but huge advances have already been made in 
quantitative analysis of the neonatal EEG and we now have algorithms that can 
accurately grade the EEG in term and preterm newborns (180, 255, 288-292). 
Multiple channels of EEG are not required to assess the grade of EEG baseline 
activity in the DR, one channel of good quality EEG is perfectly acceptable to assess 
amplitude, continuity and frequency of the EEG.  EEG sensors are constantly 
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evolving and newer disposable single application sensors are now available also 
making EEG electrode acquisition more feasible. 
EEG has long been considered just too difficult to deploy in environments like the DR 
and NICU. There have been major recent advances to the adoption of EEG in the 
NICU primarily due to technological advances (204). Modern machine learning 
techniques are also advancing rapidly and will soon be able to provide non EEG 
experts with the help needed to assist in the interpretation of EEG patterns on a 
24/7/365 basis. These difficulties should no longer be a barrier to the adoption of EEG 
in the DR and we believe further studies on EEG in the immediate newborn period are 
essential.   
In conclusion, the time is now right to advance the objective monitoring of 
neurological function of newborn infants in the DR and more research is clearly 
warranted. Future studies assessing infants following normal vaginal deliveries are a 
logical next step, and ultimately studies assessing EEG in the immediate newborn 
period following suspected HIE are warranted.  
 
6.2.2 Neuromonitoring as an outcome measure in preterm infant studies 
Developmental outcomes are the most commonly accepted outcome measures for 
interventional preterm infant studies. However, developmental outcomes are difficult 
to interpret as they are inherently multifactorial, and not solely dependent on a single 
intervention in the newborn period.  
 
Neuromonitoring in the immediate newborn period has the potential to provide 
critical real time information on preterm infant outcomes in infant studies. To date 
many investigators have concentrated on NIRS due to the simplicity of its application 
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and interpretation. EEG, however, which has proven efficacy in the management of 
term and preterm infants has been largely ignored, as its application and interpretation 
is perceived as complicated in preterm infant studies. This thesis has confirmed that 
EEG is feasible in preterm infant studies, and the information obtained is easily 
interpreted in a research setting. 
 
Advances in our understanding of preterm brain activity have led to a number studies 
describing EEG characteristics which correspond to developmental outcomes.  
Continuous displays of inter-burst interval duration, which differs with gestational 
age, has been cited as useful prognostic measure in preterm infants in the near future 
(171, 180). The most common EEG biomarkers associated with poor outcomes are 
seizures, positive rolandic sharp waves, EEG suppression/increased interburst 
intervals, mechanical delta brush activity, and other deformed EEG waveforms, 
asymmetries, and asynchronies (154).  A recent study assessing quantitative analysis 
of physiological signals, combined with gestational and graded EEG, displayed 
potential for predicting mortality or delayed neurodevelopment at 2 years of age 
(193). 
 
Therefore, infant neuromonitoring, and specifically brain activity has an important 
future role as short term outcome measures in preterm infant clinical trials. It is hoped 
that the information gathered in this thesis will contribute to international practice in 
this area.  
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BabySAFEE Consent Form Stage 1b                 Version 2.0 25 JAN 2016 P a g e  1  o f  2  
 
CONSENT BY SUBJECT FOR PARTICIPATION IN A RESEARCH PROTOCOL 
 
Study Number:                Patient Name:          
 
Title of Protocol:  
BabySAFEE: Study of Ante and Intra partum Fetal Electrocardiogram and Electroencephalography 
 
You are being asked to participate in a research study.  The doctors at University College Cork and Cork University 
Maternity Hospital (CUMH) study the nature of disease and attempt to develop improved methods of diagnosis and 
treatment.  In order to decide whether or not you want to be a part of this research study, you should understand 
enough about its risks and benefits to make an informed judgement.  This process is known as informed consent.  This 
consent form gives detailed information about the research study which will be discussed with you.  Once you 
understand the study, you will be asked to sign this form if you wish to participate. 
 
More Information about our study: 
  
What is an EEG? 
EEG stands for electroencephalography (EEG). It is a recording of the electrical activity of the brain and is 
captured using electrodes that are attached to the scalp. Electrodes are like small stickers and are easily removed 
with water or baby oil after use. 
 
What you are being asked to do? 
Enrol in our study. We are asking for your permission, to place a small set of electrodes on your baby’s scalp to 
allow us to record the electrical activity of their brain in the moments immediately after birth. We will also place 
two sticky patches on either shoulder of your baby to allow us to record your baby’s heart rate or ECG 
(electrocardiogram). EEG and ECG monitoring is routinely carried out in the Neonatal Unit of Cork University 
Maternity Hospital and causes no discomfort for the baby. We are also asking your permission to collect a sample 
of about 12mls of blood from the placenta immediately after birth. This sample will be used to measure 
biomarkers (chemicals in the blood) such as copeptin which may help us to analyse the EEG recording.  
 
How will we monitor your baby? 
After caesarean section babies are normally placed on a resuscitaire, which is like a high table, immediately after 
birth for a period of up to ten minutes. After vaginal delivery babies are placed ‘skin to skin’ with their mother. 
During this time a few small stickers (electrodes) will be placed on your baby’s head. Sometimes we cover these 
electrodes with a small hat or cap. We will record the EEG signal for a period of approximately 5- 10 minutes. If 
it is not possible to place the electrodes immediately after vaginal deliveries the recording will be postponed until 
your baby is being weighed and dressed. Taking part in this study will not interfere with ‘skin to skin’ time or 
initiating breastfeeding.  
EEG monitoring is a safe and accurate technique for monitoring brain activity in babies. We would also like to 
keep a copy of this EEG recording and some clinical information taken from your and your baby’s medical notes. 
 
What are biomarkers and how are the samples taken? 
Biomarkers are chemicals that can be found in the blood during times of stress, such as copeptin. Higher levels of 
copeptin can be detected after vaginal deliveries compared with caesarean deliveries. Copeptin levels will allow 
us to interpret your baby’s EEG reading more accurately.  
After your placenta has been delivered a small sample of blood will be taken from it through the vessels in the 
umbilical cord. This sample will be frozen and sent for analysis. This study does not involve any extra blood 
sampling for you or your baby.  
 
       Potential risks and benefits: 
The risks involved in this procedure are minimal, EEG monitoring is safe and painless and is routinely carried out 
in CUMH. 
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BabySAFEE Consent Form Stage 1b                 Version 2.0 25 JAN 2016 P a g e  2  o f  2  
Confidentiality: 
The records of this study will be kept confidential. Interesting findings from this research may be published in 
medical journals publications and presentations. All information on you and your baby will be kept anonymously 
and stored securely and only people involved in the study will have access to this information. Only personnel 
working at your hospital will have access to personal details about you or your baby and these will be stored 
securely in a locked cabinet in a restricted area accessible only to study personnel. We will not include any 
information that will make it possible to identify you as a subject. When required by law, the records of this 
research may be reviewed by government agencies and sponsors of the research. 
 
Aim of the study 
We aim collect EEG and ECG recordings during this study that will be used to identify methods to improve 
monitoring during labour and delivery.  
 
Voluntary Nature of the Study: 
Participation in this study is voluntary and you may withdraw consent at any time without affecting the medical 
care of you or your baby. 
 
Contacts and Questions: 
      Contact the Principal Investigator Dr Mairead O’Riordan Phone: 087 2329572 
      You will be given a copy of this form to keep for your records. 
 
 
AGREEMENT TO CONSENT 
The research project and the treatment procedures associated with it have been fully explained to me.  All 
experimental procedures have been identified and no guarantee has been given about the possible results.  I have had 
the opportunity to ask questions concerning any and all aspects of the project and any procedures involved.  I am 
aware that participation is voluntary and that I may withdraw my consent at any time.  I am aware that my decision 
not to participate or to withdraw will not restrict my access to health care services normally available to me.  
Confidentiality of records concerning my involvement in this project will be maintained in an appropriate manner.  
When required by law, the records of this research may be reviewed by government agencies and sponsors of the 
research. 
I understand that the sponsors and investigators have such insurance as is required by law in the event of injury 
resulting from this research. 
I, the undersigned, hereby consent to participate as a subject in the above described project conducted at the Cork 
Teaching Hospitals.  
I, the undersigned, agree to donate a sample of my baby’s umbilical cord blood for this research project. I understand 
that this sample will be retained for up to two years and discarded after analysis.  I have received a copy of 
investigator(s) listed above.  If I have further queries concerning my rights in connection with the research, I can 
contact the Clinical Research Ethics Committee of the Cork Teaching Hospitals, Lancaster Hall, 6 Little Hanover 
Street, Cork. 
 
After reading the entire consent form, if you have no further questions about giving consent, please sign where 
indicated. 
 
 
Investigator:                                                      
         Signature of Subject, Parent or Guardian 
 
             
         Signature of Subject, Parent or Guardian 
 
         
Witness:                                                 Date:                           
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Respiratory function monitoring in babies after an elective 
caesarean section: can it predict the risk for transient tachypnea 
of the newborn? 
 
Dear Parents, 
The team at Cork University Maternity Hospital are committed to providing the best care 
possible for you and your baby. Babies born by Caesarean Section have been shown to have 
an increased incidence of respiratory problems. These include transient tachypnoea of the 
newborn (wet lung) where the baby’s breathing can be rapid. This can sometimes requires 
admission into the special care baby unit where they are monitored and sometimes require 
oxygen and other breathing  support.  
The purpose of this study: 
The purpose of our study is to assess your baby’s respiratory breathing pattern in the first 
ten minutes of life and then once again after 1-2 hours. We aim to identify any indicators 
which would be used to predict those that might need admission to the unit. 
How will we monitor your baby? 
Infants will be placed on the resuscitaire immediately after birth for a period of up to  ten 
minutes which is the normal process. During this time a facemask connected to a monitor 
will be placed over your baby’s mouth and nose and their breathing patterns recorded. 
Respiratory function monitoring is a safe and accurate technique for monitoring lung 
function in babies.  The measurement causes no discomfort for the baby. 
One to two hours later we will reassess your baby’s respiratory function. This time frame has 
been chosen to allow flexibility so we do not interrupt feeding or bonding between you and 
your baby. Measurements will be taken in the same manner as at the time of delivery. 
What happens if your baby requires resuscitation at birth? 
A paediatric doctor will be present at your caesarean section which is usually not the case 
with elective sections. They will be present to assess and treat your baby. The monitor does 
not interfere with normal care or need for resuscitation. 
Confidentiality: 
While we aim to have this work presented and published internationally, your baby’s 
information will remain secure. No confidential details will be published or disclosed to 
anyone outside the study. 
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Voluntary participation: 
You are asked for voluntary consent for you and your baby to participate in this study. If you 
decide not to participate it will not have any effect on your baby’s medical care. If you do 
give consent, you are still free to withdraw from the study at any time. You do not have to 
give a reason. 
 
 
 
Research Team: 
Professor Gene Dempsey, Consultant Neonatologist, Cork University Maternity Hospital 
Dr Julie De Meulemeester, Registrar in Neonatology, Cork University Maternity Hospital 
Dr Lisa Dann, SHO in Neonatology, Cork University Maternity Hospital 
Dr Elena Pavlidis, Clinical Research Fellow, Department of Paediatrics and Child Health 
 139 
Dr Daragh Finn, Clinical Research Fellow, INFANT Research Centre 
Ita Herlihy, Clinical Research Nurse, INFANT  Research Centre 
 
Consent Form 
 
 
 
I have read the information leaflet and had all my questions answered for me............... 
I consent for my baby to be included in the study............................................................. 
I understand that I can withdraw consent at any time...................................................... 
I consent for my baby’s data to be used for the purposes of the study............................ 
 
 
Name of the baby:                                                                                                                                 _ 
Name of the parent:                                                                                                                              _ 
Signature of the parent:                                                                                                                       _ 
Date:                                                                                                                                                         _ 
 
Name of the researcher:                                                                                                                       _ 
Signature of the researcher:                                                                                                                _ 
Date:                                        _                                                                                                               _ 
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Clamping the Umbilical cord in Premature Deliveries (CUPID): A Randomised 
Controlled Pilot Trial  
Parent Information Leaflet  
 
You are being invited to give your permission for you and your baby to take part in a clinical research study. Before 
you decide it is important for you to understand why this research is being done and what it will involve. This process 
is known as informed consent. This leaflet gives detailed information about the research study, which will be 
discussed with you.  Once you understand it fully, you will be asked to sign a consent form if you are happy to take 
part. A copy of this information leaflet will be given to you to keep. If anything is unclear, or if you would like more 
information, please do not hesitate to ask us. Take all the time you need to decide if you are to take part.  
 
Why have you been invited to take part? 
Your baby is at risk of being born prematurely and so this is why the doctors have provided you with this information.  
Being born prematurely puts your baby at a higher risk of having immediate and future medical problems. The doctors 
at Cork University Maternity Hospital are trying to find the best ways to care for premature babies and their mothers’. 
One of the ways to do this is through research studies like this one.  
 
What is the study about? 
At present your baby receives all of his/her blood and oxygen from you via your placenta. The connection between 
your placenta and your baby is known as the umbilical cord. After your baby is born you are still connected until the 
doctor cuts the umbilical cord. He/she does this by placing two clamps over the cord and then cutting the cord in 
between the two clamps. We believe the timing and way in which the doctor clamps the cord may be important for 
babies born prematurely and this study is investigating what the best approach is for you and your baby.  
 
What are the different approaches to clamping the cord?  
There are three options: 
1. Immediate cord clamping: The cord will be clamped immediately (less than 20 seconds) after delivery.  
2. Delayed cord clamping: The cord will be clamped after one minute. This approach allows for extra blood to 
flow from you, and your placenta into your baby before being separated. If your baby needs help to adapt after 
delivery this will not be affected, as this help will be provided at the bedside on a mobile trolley while you and 
your baby are still attached by the umbilical cord.  
3. Umbilical Cord Milking: The doctor can ‘milk’ the cord and then clamp it. This means that the doctor will 
push blood down the umbilical cord towards your baby a few times after delivery, and then clamp the cord.  
 
Why is it important to find out which approach is best? 
Right now it is not clear which approach is best for you and your baby. Recently, studies from other countries have 
shown that by increasing the amount of blood your baby receives from you after delivery, either by delaying the 
clamping of the cord or by milking it, may result in better short term outcomes for premature babies. These include 
higher blood pressures, which are good for premature babies, less bleeds seen on head ultrasounds and less blood 
transfusions. These findings are all positive but we still do not know if they result in better long-term neurological 
outcomes for premature babies. Therefore, at present it is not clear what the best approach is, and more studies are 
required to find out. The majority still practice immediate cord clamping.  
 
How will we decide what approach is best? 
If you decide to take part we will take a blood sample from you the day after your delivery. This will help us decide 
which approach benefits mothers best. Your baby will have a number of tests all of which are routine investigations in 
premature infants. They include EEG, Cranial ultrasounds, brain oxygen monitoring, and Echo. These are all 
monitoring methods used in the intensive care unit.  They will help us decide which approach benefits babies best, by 
looking at your baby’s brain and heart function during the first days after delivery.  
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What is EEG?  
EEG stands for electroencephalography. It is a recording of the electrical activity of the brain and is captured using 
electrodes that are attached to the scalp. Electrodes are like small stickers and are easily removed with water or baby 
oil after use. They take about 10 minutes to apply and after this they will be left in place for the first few days of life. 
Our EEG system also uses video to help us study movement patterns during sleep. This video recording is strictly 
confidential and will not be used for any other purposes.  
 
What are cranial ultrasounds? 
You have seen your baby on ultrasound during your pregnancy. We will use a similar but much smaller device to look 
at your baby’s brain by ultrasound. All premature babies have a head ultrasound in the first few days of life. As part of 
the study your baby will have an extra one a few hours after being born. 
 
What is NIRS? 
Near Infrared Spectrometry (NIRS) is a method that is widely used for assessing the oxygen supply to the brain. NIRS 
is a test that picks up the oxygen level in the baby’s brain. Similar to the EEG attachments, the NIRS probe (a small 
sticker) will also be applied to your baby’s forehead and will be kept in place for the first few days of life. Once both 
tests (EEG and NIRS) are complete, these attachments will be safely removed from your baby’s head.  
 
What is echocardiography? 
We will use the ultrasound probe to look at your baby’s heart and the blood flow entering and leaving the heart.  
 
It is important to note that these methods of monitoring are standard methods of assessment of preterm infants.  
 
If I enter the study how will you decide what approach to clamping the cord will be taken? 
This is decided through a process called randomisation. This means that the approach will be assigned randomly after 
you have consented to take part in the study. Your baby will have an equal chance of being assigned to each of the 
three approaches outlined above. 
 
What will happen if I do not enter the study? 
Your baby will still have their cord clamped by one of the three approaches mentioned above. There is no hospital 
policy on umbilical cord clamping so any of these approaches may occur.   
 
Are there any risks to my baby by entering the study? 
No. There is some evidence that babies that have delayed cord clamping or umbilical cord milking can become more 
jaundiced than babies whose cords are clamped immediately. However, there is no evidence that they require more 
treatment, or that it causes any harm to babies.   
 
Voluntary Nature of the Study: 
Participation in this study is voluntary and you may withdraw consent at any time without affecting the medical care of 
you or your baby. You can also ask to speak with a member of the research team at any time during the study and we 
would be happy to answer any questions that you may have.   
 
Confidentiality: 
The records of this study will be kept confidential. Interesting findings from this research may be published in medical 
journal publications and presentations. All information on you and your baby will be kept anonymously and stored 
securely and only people involved in the study will have access to this information. Only personnel working on the 
study will have access to personal details about you or your baby and these will be stored securely in a locked cabinet 
in a restricted area accessible only to study personnel. We will not include any information that will make it possible to 
identify you as a subject.  
 
 
 
 
 142 
                                                  
 
 
 
3 
 
 
Contact Details for Chief Investigator: 
 
 
         Prof Eugene Dempsey 
    Consultant Neonatologist 
    INFANT Research Centre 
    Cork University Maternity Hospital 
    Wilton 
    Ireland 
    Tel: 0214920500 
 
 
  
 
 
  
Version 2.1 
23/10/2015 
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 We reviewed the current available literature on this 
important aspect of newborn care, in an effort to uncover 
the evidence to support the use of VR in the DR. We re-
viewed (1) how to determine which infants may benefit 
from VR, (2) the indication and frequency of VR in the 
DR, (3) which fluid should be used, and, lastly (4) wheth-
er there is a role for placental transfusion in such infants. 
 How to Determine Which Infants Require VR 
 In newborn term and preterm infants, the practice of 
VR is often considered to be beneficial, for instance, in 
severe arterial hypotension or severe metabolic acidosis 
in the context of neonatal shock  [2, 3] . Shock is caused by 
an acute failure of circulatory function and is character-
ized by inadequate tissue and organ perfusion  [4] , and is 
most commonly caused by an asphyxial insult and/or hy-
povolaemia in newborn infants where there may/may not 
be obvious blood loss and also in the setting of sepsis.
 VR can be lifesaving for newborn infants with hypo-
volaemic shock or sepsis. However, infants who sustain 
an acute perinatal asphyxial insult, not secondary to acute 
blood loss, are generally euvolaemic  [2] . In cases of intra-
uterine hypoxia, there is often an increased blood volume 
 [5, 6] . VR in such infants may lead to volume overload 
and worsen cardiovascular compromise in infants who 
may have impaired myocardial contractility  [2, 7] . How-
ever, in a compromised term neonate in the DR, distin-
guishing an infant with hypovolaemic shock from a nor-
movolaemic infant with asphyxia is challenging.
 ILCOR advises clinical assessments of peripheral per-
fusion to differentiate between the normovolaemic and 
hypovolaemic state  [1] . In the 2010 ILCOR report as well 
as in the 2015 European Resuscitation Committee (ERC) 
guidelines, the colour of the mucous membranes was said 
to be a useful clinical discriminator  [8, 9] . In the case of 
hypovolaemic shock, these membranes will be pale, but 
in the case of asphyxia, they may have a “normal” colour 
 [10] . However, assessments such as capillary refill time, 
colour, and palpation of peripheral pulses are subjective, 
and there can be significant inter-rater variability, as 
highlighted by several investigators  [11, 12] . Assessments 
based on the colour of the mucous membranes, although 
specific if oxygen saturations are <70%, are still subjec-
tive, and are associated with a low sensitivity  [13] , making 
it difficult to clinically determine the underlying aetiology 
of newborn shock.
 Objective measures of newborn circulatory status are 
an important component of assessing infants with shock 
in the DR, both for diagnosing circulatory failure and to 
monitor the response to treatment. We will discuss the 
 Table 1.  Objective monitors for assessing newborn circulatory status in the DR
Normative values
established for
term infants1
Normative values
established for
preterm infants2
Accuracy Comments
Pulse oximetry HR + + + gold standard monitor for assessing HR in the DR; may 
be unreliable during CPR
ECG HR + + + quicker data acquisition than pulse oximetry but may 
require extra personnel
Doppler US HR + + + a novel method for accurate data acquisition but extra 
trained personnel required
BP + – – accurate measurements not feasible in the DR setting
ECHO-LVO/RVO + – + supplies valuable information but extra trained 
personnel required
NICOM-LVO + – – limited as only trends in CO can be appreciated; further 
studies advised
 BP, blood pressure; CO, cardiac output; DR, delivery room; ECHO, echocardiogram; ECG, electrocardiogram; HR, heart rate; LVO, 
left ventricular output; RVO, right ventricular output; NICOM, non-invasive cardiac-output monitoring; US, ultrasound.
1 In the immediate newborn period; 2 <32 weeks’ gestation in the immediate newborn period.
D
o
w
n
lo
a
d
e
d
 b
y
: 
9
4
.1
3
.1
7
1
.2
3
0
 -
 9
/1
6
/2
0
1
7
 2
:4
7
:5
5
 P
M
 
 184 
 Newborn Volume Resuscitation Neonatology 2017;112:163–171
DOI: 10.1159/000475456
165
methods used for heart rate (HR) and blood pressure (BP) 
assessment in the DR, and also newer modalities such as 
echocardiography (ECHO), perfusion index (PI), and 
non-invasive cardiac monitoring (NICOM) ( Table 1 ).
 Assessment of newborn HR has been the mainstay to 
assess effective newborn transition and to gauge the need 
for resuscitatory interventions in the DR  [1] . Methodolo-
gies include assessment by stethoscope auscultation, pal-
pation, pulse oximetry, electrocardiogram (ECG), and 
Doppler ultrasound. While the clinical assessment of HR 
by auscultation at the apex with a stethoscope is more ac-
curate than the assessment of umbilical pulsations  [14] , 
these methodologies are often inaccurate compared with 
other objective methods, such as pulse oximetry and ECG 
 [9] . A recent commentary has highlighted that a pro-
longed time period to auscultate may provide a more ac-
curate HR  [15] .
 Assessing HR from pulse oximetry readings provides 
real-time accurate information  [16] , but there can be de-
lays in signal acquisition of between 1 and 2 min  [17] , and 
especially in low-perfusion states  [18] . Whilst pulse oxim-
etry is easy to apply by using a single probe, preferably on 
the right hand (pre-ductal) of the neonate, in depressed 
neonates with poor cardiac output, lack of signal may be 
confused with handling errors or device failure, and hence 
distract from managing the clinical state of the infant. In 
addition to the HR, pulse oximetry also provides oxygen 
saturation data on a continuous basis. Similarly to the 
abovementioned errors associated with obtaining oxygen 
saturation signals, pulse oximetry-derived HR can be ad-
versely affected by improper application, movement arti-
fact, or poor peripheral perfusion, and so may not be reli-
able while performing chest compressions  [19] .
 Evaluation of the HR by means of ECG has been shown 
to provide more accurate HR values, in a shorter time 
than pulse oximetry HR in the DR, and it is less prone to 
movement artifact. Katheria et al.  [20] reported median 
times for acquiring a signal from ECG and pulse oximetry 
of 4 and 32 s following application, respectively. Howev-
er, obtaining an ECG requires the application of 3 chest 
leads; this may itself take up to 20s  [20] . In practice, a 
baby’s wet skin may also pose a challenge, as not all ECG 
leads stick well to a wet surface and so the task of applying 
the leads may require additional personnel. Furthermore, 
pulseless electrical activity can present with a visible ECG, 
but no cardiac output, even though this is an extremely 
rare occurrence in the newborn.
 Hutchon  [21] showed that measurement of the neona-
tal HR by Doppler ultrasound is possible, and can easily 
be seen as an extension of fetal HR monitoring until pulse 
oximetry readings are available. Measurements are accu-
rate and comparable with ECG HR values  [22] . This ap-
proach may be challenging, as clinical expertise is re-
quired for accurate ultrasound assessments and, at pres-
ent, continuous measurements are not practical. In 
conclusion, the assessment of HR is important. To date, 
the accuracy of routinely applied methods varies, with 
palpation and auscultation being the least accurate and 
ECG being the most accurate  [23] .
 Neonatal oscillometric BP monitoring is another ob-
jective methodology that has been investigated during 
neonatal transition, although not widely used clinically. 
A number of studies have shown that BP measurements 
are obtainable in the DR  [24, 25] . However, such non-
invasive BP measurements are not reliably consistent, es-
pecially in preterm neonates, and invasive BP monitoring 
is not practical in the DR setting  [3] . Thus, BP acquisition 
and values obtained in the DR may not be clinically useful 
in assessing the circulatory status of newborn infants.
 A recent review identified 4 studies of cardiac-output 
ECHO monitoring during term newborn stabilization 
 [24] . These studies confirm that ECHO assessment of 
neonatal transition (ductal haemodynamics, and changes 
in right and left ventricular outputs) is feasible as an ob-
jective adjunct to determining newborn haemodynamic 
status  [26–28]  . Normative ECHO values for left ventricu-
lar output and stroke volume in the first 15 min of life 
have been determined  [27, 29] . Therefore, in theory, 
ECHO could help distinguish between infants who pres-
ent with low-output cardiac failure in the setting of hypo-
volaemic shock, and high-output failure in the setting of 
asphyxia. However, studies have yet to assess whether 
ECHO analysis could help in determining the aetiology 
of newborn shock or volume responsiveness in the new-
born period, and whether this approach is indeed useful 
to guide clinical decision-making  [30] .
 Weisz et al.  [31] described a method which provides 
non-invasive continuous cardiac-output monitoring 
(NICOM). This technology is based on the assumption 
that changes in the resistance to electrical currents cap-
tured by electrodes on the thorax are directly related to 
changes in aortic volume during different stages of the 
cardiac cycle. NICOM measurements correlate well with 
timed ECHO measurements in neonates  [31] . However, 
NICOM underestimates the actual cardiac-output value 
(47% error reported)  [31] . Therefore, it may be more use-
ful in monitoring trends in cardiac output. It is not de-
signed to help in discriminating between causes of new-
born shock or volume responsiveness in the newborn pe-
riod, and a systematic review of NICOM confirmed that 
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it is not accurate in determining volume responsiveness 
in paediatric patients  [30] . Katheria et al.  [32] document-
ed increasing cardiac outputs on NICOM over the first 5 
min of life in term infants during delayed umbilical-cord 
clamping, and, although feasible, at present, NICOM is 
not a valuable tool for assessing infants in the DR.
 PI monitoring is a non-invasive method of assessing 
peripheral perfusion and provides continuous values. 
These values are derived from and displayed by a pulse 
oximeter, which utilizes an extra wavelength emission in 
its calculations to distinguish between the pulsatile and 
non-pulsatile components of arterial blood, and produc-
es a real-time measure of peripheral perfusion  [33] . The 
PI has been utilized to assess infants in a number of clin-
ical domains in the NICU setting  [34] . These include elec-
tive screening for congenital cardiac disease  [35] , predict-
ing low systemic blood flow  [36] , and assessing perfusion 
following blood transfusion  [37] . Values for PI are also 
easily obtained in the DR  [38] . However, they are highly 
variable in the immediate newborn period, for both term 
and preterm infants, which limits the use of PI in assess-
ing newborn circulatory status in the DR  [38, 39] .
 Near-infrared spectrospcopy (NIRS) may be a useful 
adjunct, and there have been a number of recent DR-ori-
entated studies addressing the use of NIRS  [40, 41] . It is 
easy to apply and there is very little delay in signal acqui-
sition. NIRS has been utilized to assess the adequacy of 
peripheral oxygenation  [42] . Wardle et al.  [43]  evaluated 
oxygen delivery and consumption in the forearm of 30 
preterm babies, 15 of whom were hypotensive by Watkins 
criteria. They identified a lower oxygen delivery and con-
sumption in the hypotensive babies. However, NIRS has 
yet to demonstrate that its use results in improved out-
comes for term and preterm infants.
 In summary, there appears to be no single failsafe or 
reliable clinical or electronic modality that accurately de-
lineates haemodynamic status in the healthy or sick neo-
nate during transition. Objective HR assessment remains 
important. The typical description of acute blood loss or 
hypovolaemic circulation has been that “pallor of the 
mucous membranes and skin is nearly always present” 
 [44, 45] . We contend that this clinical sign is a very poor 
discriminator between acute blood loss and asphyxia, 
and that the utilization of other objective parameters 
(BP, ECHO, NICOM, and PI) may allow for better dis-
crimination between these 2 broad categories in the fu-
ture. However, the sensitivity and specificity of these pa-
rameters, individually or collectively, remains to be de-
termined.
 The Frequency of VR in the DR 
 Although the incidence of neonatal shock remains un-
known, <1% of newborn infants require advanced resus-
citative measures, including chest compression, drug ad-
ministration, and fluid boluses during newborn stabiliza-
tion  [46] . Wyckoff et al.  [2] described a cohort of 37,972 
infants of >34 weeks’ gestation delivered over a 30-month 
period, 28 of whom (0.07%) received intensive CPR. This 
was defined as the need for >60 s of positive pressure ven-
tilation and chest compressions, with or without the ad-
ministration of medications. Five infants did not respond 
to these interventions (including VR in at least 4 of these 
cases) and died in the DR. Of the remaining 23 infants ad-
mitted to the NICU, 13 had received VR. Therefore, in this 
cohort of infants delivered at >34 weeks’ gestation, only 
0.04% (4.4/10,000) received VR in the DR. The authors 
compared the infants that had received VR ( n = 13) with 
those who had not ( n = 10). The patients who received 
volume were more likely to have low Apgar scores (Apgar 
<2 at 5 and 10 min), to have a lower cord pH, and to have 
received adrenaline in the DR and their mean resuscita-
tion times were longer in duration (8 vs. 4 min). The mean 
BP on admission was lower (32 vs. 49 mm Hg) and initial 
haematocrit was also lower (41 vs. 54) in the group who 
received volume. In the 13 infants who received VR, the 
clinical indication for the initial use of volume was an in-
adequate HR despite CPR and adrenaline administration 
in 10 cases, and poor perfusion coupled with a clinical 
suspicion of acute blood loss in the other 3. It is difficult 
to tease out the underlying aetiology of shock from this 
retrospective study, other than to say that the majority of 
infants who received volume were hypotensive on arrival 
to the NICU, but the majority of those who did not receive 
volume were not. The aetiology of newborn shock is mul-
tifactorial, and determining the difference between acute 
blood loss and asphyxia based on BP values upon admis-
sion is challenging. From this retrospective study, one can 
conclude that sicker babies (lower Apgar score, lower cord 
pH, in receipt of adrenaline) are more likely to receive VR, 
which is consistent with current resuscitation guidelines.
 Overall, there is rather limited information available 
and there are no comparative studies to assess variations 
in practice between neonatal centers. We know that VR 
is rare, but there is a paucity of available research to quan-
tify just how often it occurs. Future resuscitation commit-
tees should reach a consensus on a definition for newborn 
shock if studies are to be of value. Without further data, 
it will be challenging to perform comparative studies or 
best-practice reviews on VR in the DR.
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 What Agent Should Be Administered in 
Hypovolaemic Neonates? 
 International guidelines generally advise that, when 
hypovolaemic shock is suspected, emergency un-cross-
matched O-Rhesus-negative blood should be adminis-
tered whenever available ( Table 2 )  [1] . If not, isotonic 
crystalloid fluids should be given. Colloid infusions such 
as albumin are no longer advised as a treatment option 
during DR stabilizations  [9, 44] . However, the suggestion 
stems from extrapolation of data from studies on animal 
models and older children, as there is a paucity of neona-
tal or DR studies. The ideal amount to be transfused is 
unclear, but an initial 10–20 mL/kg may be appropriate, 
considering that DCC may result in an additional 30% 
blood transfer.
 Whole blood provides volume, oxygen-carrying ca-
pacity, and colloids, and is the most rational agent to ad-
minister in the setting of acute blood loss. Transfusion of 
blood products carries a small risk of infectious transmis-
sion (in the order of viral contamination in 1/1–1.3 new-
borns)  [47] , which may be particularly harmful towards 
extremely-low-birth-weight infants who are already im-
munologically compromised and neurodevelopmentally 
vulnerable  [48] . Haemolytic transfusion reactions are 
rare in newborn infants  [49] . We recently reviewed our 
own practice (Medical Centre, University College Cork, 
Cork, Ireland) in relation to the administration of emer-
gency un-cross-matched blood in the DR. Over a 5-year 
period, there were 42,657 births, and 6 infants (1.4/10,000 
live births) received an emergency blood transfusion in 
the DR  [50] . Neither delayed cord clamping nor milking 
was routinely practiced in our DR in this time frame. The 
indication for administration of whole blood was based 
on a non-response to intensive CPR and a history of pos-
sible blood loss (e.g., vasa previa, fetomaternal haemor-
rhage, or placental abruption). However, generally speak-
ing, whole blood is not readily available and the adminis-
tration of crystalloid occurs in the first instance. This 
figure is greater than the DR volume administration rate 
reported by Wyckoff et al. [2] , where 3 infants received 
volume because of concerns about acute blood loss 
(0.8/10,000).
 There is no data from DR resuscitations comparing the 
efficacy of crystalloid or colloid agents. Albumin is the 
most abundant protein in plasma, and, during normal 
homeostasis, is responsible for maintaining 60–80% of 
colloid osmotic pressure. Much of the data on crystalloid 
or colloid use has been derived from the management of 
preterm infants at risk of/with established hypotension 
 [51] . Neonatal studies to date performed outside the DR 
setting have displayed no difference in efficacy between 
colloid and crystalloid infusions  [52, 53] , and crystalloids 
are generally the preferred agent for many practical rea-
sons: they are readily available, cheaper, and carry a low-
er risk of infectious complications  [45] . Synthetic colloid 
volume expanders are as effective as albumin, have no 
infectious risks, and are readily available  [54] . However, 
they are also expensive compared to crystalloids, and 
concerns have been raised in the past regarding different 
solutions disturbing paediatric coagulation systems  [55] . 
Therefore, when whole blood is not available, the admin-
istration of crystalloid volume is advised for the treatment 
of newborn hypovolaemic shock.
 The volume to be infused and the rate of infusion have 
not been studied in neonates. However, it should be not-
ed that there is animal data which raises a number of 
concerns related to the rapid administration of volume 
expanders  [7, 56] . Wyckoff et al.  [7] compared 5% albu-
min, normal saline, and no volume on the development 
 Table 2.  Volume resuscitation agents in hypovolaemic shock
Availability Efficacy Risk Cost Recommendation
O-Rhesus-negative blood centre-
dependent
most efficacious low a valuable
resource
gold standard treatment for 
hypovolaemic shock
Crystalloid (NaCl 0.9%) readily equal to albumin none – first-line agent when whole 
blood is not available
Albumin readily equal to crystalloid and
synthetic volume expander
low + not recommended
Synthetic volume expander readily equal to albumin low + not recommended
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of pulmonary oedema and the restoration of mean arte-
rial pressure during the resuscitation of asphyxiated pig-
lets. Volume administration in these animals did not im-
prove mean arterial BP. The authors demonstrated an 
increased risk of pulmonary oedema in the piglets when 
albumin was administered compared to the control ani-
mals. Another study evaluated the effect of rapid volume 
administration on coagulation haemostasis in piglets, 
comparing 4 different fluids including normal saline and 
albumin  [56] . These piglets were not hypovolaemic. All 
fluids administered caused a significant weakening of 
clot strength, suggesting that rapid volume administra-
tion can impact upon the coagulation profile. Therefore, 
the potential side effects of the rapid administration of 
crystalloids or colloids in the DR setting need to be care-
fully considered.
 Is There a Role for Placental Transfusion in 
Compromised Infants? 
 The 2015 ILCOR and ERC guidelines advocate de-
layed cord clamping (DCC, for at least 1 min) in uncom-
promised term and preterm infants  [1, 9] . This is based 
on a plethora of benefits outlined in recent Cochrane re-
views for both term and preterm infants, such as reduced 
incidences of anemia, hypotension, and intraventricular 
haemorrhage following DCC  [57, 58] . However, the au-
thors advise that, until further evidence is available, pla-
cental transfusion should be discontinued in infants who 
are not breathing, so that resuscitation measures are not 
delayed  [1] . They acknowledge that even though there is 
compelling physiological data from animal studies to 
suggest many benefits to resuscitating depressed new-
borns whilst on the cord, such a recommendation has not 
been formulated in the ILCOR or ERC guidelines due to 
the lack of human studies on the feasibility and safety of 
this approach  [59, 60] . First-in-human studies are cur-
rently underway.
 Newborns that require resuscitation at birth are at a 
higher risk of brain injury and death, and some commen-
tators have argued that these infants may receive the 
greatest benefit from DCC  [61] . In the setting of hypovo-
laemic shock, fresh whole blood which supplies volume 
expansion, colloid expansion, and oxygen-carrying ca-
pacity may be considered an ideal agent  [62] . The benefits 
of DCC are thought to result from a number of physio-
logical processes that include (1) the placental transfer of 
blood, (2) accommodating a more stable haemodynamic 
transition from fetal life, and (3) a transfer of stem cells.
 The volume and rate of delivery of placental blood as 
a result of DCC was thought to be increased if the infant 
was placed in a superior position relative to the placenta 
when uterine contractions are present and if newborn 
respiration has commenced  [63–65] . However, recent 
studies suggest that the position of the newborn may not 
have much influence on the volume of blood transfused 
 [66, 67] . Placental transfusion can result in a direct intra-
vascular transfusion of 30–40% of the total neonatal 
blood volume  [63–65, 68] . For infants with hypovolaemic 
shock, DCC could be an important first step in their re-
suscitation, if early identification was possible  [69] . For 
preterm infants (<32 weeks’ gestaion), an increase in total 
blood volume results in higher BP and a reduced need for 
inotropic support, with no significant side effects  [57] . 
Conversely, it is unknown whether asphyxiated infants 
will benefit from placental transfusion and whether DCC 
could be deleterious due to the potential for volume over-
load, polycythemia, and the possible delay in establishing 
positive pressure ventilation  [70] .
 DCC may facilitate a more stable haemodynamic tran-
sition for compromised infants  [61] . In preterm infants, 
it was associated with a 50% reduction in intraventricular 
haemorrhage (although not significant for grade 3 or 4), 
which can be explained by the increase in fluctuations of 
cardiac output which follow immediate cord clamping 
 [57, 71, 72] .
 DCC also increases the transfer of haematopoietic 
stem cells, endothelial cell precursors, mesenchymal pro-
genitors, and pluripotent lineage stem cells  [73] . Stem cell 
therapies are under investigation for the early treatment 
of developmental brain injury, including perinatal as-
phyxia and preterm birth  [74, 75] . The evidence to date 
supports that cord blood cells may provide neuro-protec-
tive benefits due to their actions on a range of comple-
mentary biochemical pathways that become dysregulated 
in response to perinatal asphyxia  [76] . Autologous umbil-
ical-cord blood mononuclear cells in asphyxiated new-
born lamb and rat models restore normal brain metabo-
lism, and reduce brain inflammation, astrogliosis, and 
neuronal apoptosis  [74, 77, 78] . Studies to date have con-
centrated on autologous transfusions, and the placental 
transfusion of stem cells by DCC has yet to be studied in 
vivo. Therefore DCC for infants in need of resuscitation 
cannot be recommended based on the transfer of stem 
cells alone  [76] .
 Strategies that allow for placental transfusions but do 
not delay resuscitative measures are currently under eval-
uation, as mentioned earlier. Newborn resuscitation at 
the bedside while the cord is still attached is now feasible 
D
o
w
n
lo
a
d
e
d
 b
y
: 
9
4
.1
3
.1
7
1
.2
3
0
 -
 9
/1
6
/2
0
1
7
 2
:4
7
:5
5
 P
M
 
 188 
 Newborn Volume Resuscitation Neonatology 2017;112:163–171
DOI: 10.1159/000475456
169
with the introduction of mobile resuscitation trolleys 
 [79] . Another strategy that allows for placental transfu-
sion at birth and does not delay neonatal resuscitation is 
umbilical-cord milking, which has the advantage of trans-
fusing similar volumes without delaying routine neonatal 
resuscitation  [80] . Short-term benefits similar to those 
with DCC for preterm infants have been reported  [81] . 
However, there is still a dearth of knowledge about um-
bilical-cord milking, with concerns that multiple strip-
ping of the cord could release harmful cytokines or cel-
lular debris into the infant’s circulation so, at present, 
guidelines do not recommend it following term or pre-
term deliveries  [61] .
 While DCC may be appropriate when haemorrhagic 
shock is presumed, the same difficulties in distinguishing 
such infants from other compromised infants remain. 
Further research on stem cell transplants, bedside resus-
citation measures, and umbilical-cord milking are war-
ranted.
 Conclusion 
 In a setting with presumed or obvious blood loss such 
as placental abruption or fetal-to-maternal transfusion, 
VR therapy may indeed have an important role to play. 
However, for other clinical scenarios such as asphyxia, 
the current set of clinical and technical tools makes it dif-
ficult to differentiate the haemodynamically compro-
mised infant who will benefit from volume therapy from 
the normovolaemic asphyxiated infant who may, poten-
tially, be further compromised by volume therapy. When 
the decision to treat is made, fresh whole blood should be 
used if available, and crystalloid solutions if not. DCC re-
mains the most obvious source for immediate transfusion 
in such infants but, currently, it is unknown if DCC is 
beneficial in the setting of haemorrhagic shock, and fur-
ther work is needed to assess whether DCC with ventila-
tory support results in better outcomes for compromised 
infants at birth.
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